| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Occupational Exposure | 194 | 2022 | 1807 | 18.980 |
Why?
|
| Arsenic | 62 | 2024 | 358 | 13.800 |
Why?
|
| Lung Neoplasms | 256 | 2024 | 13586 | 11.470 |
Why?
|
| Air Pollutants, Occupational | 62 | 2020 | 406 | 10.290 |
Why?
|
| Welding | 33 | 2020 | 89 | 8.930 |
Why?
|
| Occupational Diseases | 86 | 2020 | 1457 | 8.590 |
Why?
|
| Polymorphism, Genetic | 102 | 2020 | 4249 | 8.140 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 86 | 2024 | 5432 | 7.020 |
Why?
|
| Environmental Exposure | 90 | 2024 | 4543 | 6.150 |
Why?
|
| Smoking | 157 | 2024 | 9092 | 5.680 |
Why?
|
| Textile Industry | 32 | 2015 | 74 | 5.270 |
Why?
|
| Endotoxins | 31 | 2019 | 519 | 5.120 |
Why?
|
| Polymorphism, Single Nucleotide | 136 | 2024 | 16045 | 4.540 |
Why?
|
| Particulate Matter | 40 | 2021 | 2617 | 4.370 |
Why?
|
| Dust | 37 | 2015 | 488 | 4.150 |
Why?
|
| Metals | 21 | 2021 | 713 | 4.130 |
Why?
|
| Glutathione Transferase | 27 | 2019 | 564 | 3.970 |
Why?
|
| Inhalation Exposure | 22 | 2020 | 432 | 3.900 |
Why?
|
| Bangladesh | 51 | 2024 | 742 | 3.780 |
Why?
|
| Arsenic Poisoning | 12 | 2020 | 55 | 3.650 |
Why?
|
| Genetic Predisposition to Disease | 135 | 2024 | 18065 | 3.580 |
Why?
|
| Water Pollutants, Chemical | 18 | 2024 | 359 | 3.480 |
Why?
|
| Esophageal Neoplasms | 27 | 2020 | 1668 | 3.450 |
Why?
|
| DNA Methylation | 31 | 2024 | 4428 | 3.450 |
Why?
|
| Adenocarcinoma | 56 | 2020 | 6395 | 3.430 |
Why?
|
| Asbestos | 30 | 2017 | 251 | 3.380 |
Why?
|
| Maternal Exposure | 19 | 2024 | 1096 | 3.210 |
Why?
|
| Cotton Fiber | 14 | 2013 | 25 | 2.950 |
Why?
|
| Heart Rate | 24 | 2019 | 4214 | 2.910 |
Why?
|
| China | 94 | 2021 | 2395 | 2.790 |
Why?
|
| Nails | 19 | 2021 | 298 | 2.740 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 26 | 2023 | 3252 | 2.680 |
Why?
|
| Genome-Wide Association Study | 86 | 2024 | 12795 | 2.630 |
Why?
|
| Case-Control Studies | 160 | 2024 | 22291 | 2.610 |
Why?
|
| Environmental Monitoring | 39 | 2017 | 1469 | 2.610 |
Why?
|
| Byssinosis | 21 | 2013 | 36 | 2.530 |
Why?
|
| Air Pollutants | 29 | 2021 | 2916 | 2.510 |
Why?
|
| Lung | 62 | 2024 | 10099 | 2.510 |
Why?
|
| Male | 602 | 2024 | 364719 | 2.500 |
Why?
|
| Respiratory Tract Diseases | 17 | 2024 | 744 | 2.480 |
Why?
|
| Humans | 894 | 2024 | 768166 | 2.440 |
Why?
|
| Middle Aged | 448 | 2024 | 223492 | 2.420 |
Why?
|
| Environmental Pollutants | 22 | 2024 | 1296 | 2.410 |
Why?
|
| Fires | 18 | 2014 | 170 | 2.280 |
Why?
|
| Acute Lung Injury | 11 | 2022 | 377 | 2.270 |
Why?
|
| Lung Diseases | 21 | 2023 | 1944 | 2.210 |
Why?
|
| Female | 545 | 2024 | 397192 | 2.190 |
Why?
|
| Adult | 419 | 2024 | 223646 | 2.150 |
Why?
|
| Genotype | 104 | 2023 | 13045 | 2.090 |
Why?
|
| Forced Expiratory Volume | 33 | 2022 | 1831 | 1.930 |
Why?
|
| Epigenesis, Genetic | 14 | 2024 | 3833 | 1.930 |
Why?
|
| Gossypium | 15 | 2007 | 36 | 1.870 |
Why?
|
| Asbestos, Serpentine | 4 | 2017 | 24 | 1.860 |
Why?
|
| Occupational Health | 21 | 2022 | 812 | 1.860 |
Why?
|
| Fetal Blood | 13 | 2021 | 1361 | 1.830 |
Why?
|
| Carcinoma, Squamous Cell | 27 | 2020 | 4058 | 1.820 |
Why?
|
| Aged | 283 | 2024 | 171504 | 1.810 |
Why?
|
| Deoxyguanosine | 8 | 2010 | 96 | 1.810 |
Why?
|
| Asbestosis | 19 | 2017 | 81 | 1.750 |
Why?
|
| Xeroderma Pigmentosum Group D Protein | 11 | 2015 | 105 | 1.730 |
Why?
|
| Mining | 9 | 2018 | 93 | 1.720 |
Why?
|
| Risk Factors | 204 | 2024 | 74944 | 1.720 |
Why?
|
| Textiles | 10 | 2015 | 44 | 1.690 |
Why?
|
| DNA Adducts | 9 | 2015 | 95 | 1.690 |
Why?
|
| Hazardous Substances | 13 | 2016 | 153 | 1.680 |
Why?
|
| Carcinogens | 14 | 2024 | 453 | 1.670 |
Why?
|
| Skin Diseases | 8 | 2016 | 1085 | 1.640 |
Why?
|
| Spirometry | 29 | 2022 | 929 | 1.590 |
Why?
|
| Accidents, Occupational | 11 | 2017 | 251 | 1.590 |
Why?
|
| Autonomic Nervous System | 7 | 2017 | 707 | 1.590 |
Why?
|
| Infant, Low Birth Weight | 10 | 2022 | 871 | 1.540 |
Why?
|
| Haplotypes | 19 | 2014 | 2722 | 1.440 |
Why?
|
| Elafin | 4 | 2014 | 30 | 1.410 |
Why?
|
| Lead | 12 | 2022 | 882 | 1.410 |
Why?
|
| Air Pollution | 16 | 2021 | 2374 | 1.410 |
Why?
|
| Coal | 5 | 2019 | 122 | 1.380 |
Why?
|
| Genes, p53 | 13 | 2007 | 714 | 1.370 |
Why?
|
| Survival Analysis | 41 | 2024 | 10101 | 1.360 |
Why?
|
| Tobacco Smoke Pollution | 13 | 2016 | 828 | 1.360 |
Why?
|
| Carbon | 11 | 2019 | 673 | 1.350 |
Why?
|
| Fuel Oils | 9 | 2005 | 36 | 1.350 |
Why?
|
| Mycotoxins | 2 | 2020 | 35 | 1.340 |
Why?
|
| DNA Damage | 19 | 2022 | 2469 | 1.330 |
Why?
|
| Leukocytes | 11 | 2019 | 2035 | 1.330 |
Why?
|
| Oxidative Stress | 17 | 2016 | 3139 | 1.270 |
Why?
|
| DNA-Binding Proteins | 18 | 2022 | 9615 | 1.260 |
Why?
|
| Heart | 9 | 2017 | 4446 | 1.250 |
Why?
|
| Manganese | 11 | 2022 | 394 | 1.240 |
Why?
|
| Cohort Studies | 90 | 2024 | 41754 | 1.230 |
Why?
|
| DNA Repair | 22 | 2017 | 2050 | 1.230 |
Why?
|
| Prognosis | 69 | 2024 | 30010 | 1.230 |
Why?
|
| Birth Weight | 10 | 2019 | 2121 | 1.230 |
Why?
|
| Power Plants | 9 | 2019 | 125 | 1.230 |
Why?
|
| Folic Acid | 6 | 2024 | 1337 | 1.220 |
Why?
|
| Endonucleases | 8 | 2015 | 371 | 1.210 |
Why?
|
| Linear Models | 32 | 2017 | 5884 | 1.180 |
Why?
|
| Pyrenes | 10 | 2010 | 51 | 1.160 |
Why?
|
| CpG Islands | 12 | 2024 | 1208 | 1.160 |
Why?
|
| Automobile Driving | 7 | 2005 | 442 | 1.150 |
Why?
|
| Epigenomics | 6 | 2020 | 960 | 1.140 |
Why?
|
| Metals, Heavy | 7 | 2019 | 149 | 1.140 |
Why?
|
| Epistasis, Genetic | 4 | 2020 | 353 | 1.120 |
Why?
|
| Water Supply | 12 | 2016 | 204 | 1.110 |
Why?
|
| Odds Ratio | 47 | 2020 | 9669 | 1.110 |
Why?
|
| Risk | 29 | 2019 | 9613 | 1.100 |
Why?
|
| Smoking Cessation | 10 | 2023 | 2085 | 1.100 |
Why?
|
| Body Mass Index | 28 | 2021 | 13053 | 1.090 |
Why?
|
| Small Cell Lung Carcinoma | 5 | 2019 | 454 | 1.090 |
Why?
|
| Air Pollution, Indoor | 7 | 2022 | 931 | 1.080 |
Why?
|
| Particle Size | 26 | 2016 | 1649 | 1.080 |
Why?
|
| Taiwan | 28 | 2016 | 521 | 1.070 |
Why?
|
| Occupations | 11 | 2014 | 516 | 1.070 |
Why?
|
| DNA, Neoplasm | 10 | 2019 | 1744 | 1.060 |
Why?
|
| Metallurgy | 12 | 2010 | 90 | 1.060 |
Why?
|
| Logistic Models | 55 | 2018 | 13290 | 1.060 |
Why?
|
| Epoxide Hydrolases | 7 | 2014 | 122 | 1.060 |
Why?
|
| Gene Expression Profiling | 22 | 2021 | 9538 | 1.060 |
Why?
|
| Electrocardiography, Ambulatory | 11 | 2016 | 582 | 1.060 |
Why?
|
| Industry | 18 | 2014 | 362 | 1.050 |
Why?
|
| Lung Diseases, Obstructive | 8 | 2022 | 311 | 1.040 |
Why?
|
| Coke | 7 | 2014 | 21 | 1.040 |
Why?
|
| Carcinogens, Environmental | 5 | 2018 | 70 | 1.030 |
Why?
|
| Agriculture | 6 | 2015 | 186 | 1.030 |
Why?
|
| Alleles | 25 | 2024 | 6894 | 1.030 |
Why?
|
| Bicycling | 2 | 2018 | 177 | 1.020 |
Why?
|
| Metabolomics | 7 | 2021 | 1674 | 1.020 |
Why?
|
| Benzene | 11 | 2018 | 106 | 1.010 |
Why?
|
| Flavoring Agents | 6 | 2021 | 53 | 1.010 |
Why?
|
| Respiratory Function Tests | 20 | 2022 | 1695 | 1.010 |
Why?
|
| Superoxide Dismutase | 7 | 2008 | 596 | 1.010 |
Why?
|
| Motor Vehicles | 3 | 2018 | 280 | 1.000 |
Why?
|
| Nicotine | 5 | 2022 | 680 | 1.000 |
Why?
|
| Isoenzymes | 7 | 2007 | 1688 | 1.000 |
Why?
|
| Aged, 80 and over | 97 | 2024 | 59629 | 0.990 |
Why?
|
| Meningomyelocele | 3 | 2017 | 182 | 0.980 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 6 | 2013 | 362 | 0.980 |
Why?
|
| Platelet Count | 6 | 2020 | 787 | 0.970 |
Why?
|
| Pregnancy | 51 | 2024 | 30256 | 0.950 |
Why?
|
| Beta Particles | 1 | 2024 | 52 | 0.950 |
Why?
|
| Pulmonary Fibrosis | 5 | 2023 | 506 | 0.950 |
Why?
|
| Chemical Industry | 12 | 2006 | 115 | 0.950 |
Why?
|
| Smoke | 5 | 2021 | 242 | 0.950 |
Why?
|
| Glutathione S-Transferase pi | 9 | 2007 | 99 | 0.940 |
Why?
|
| Rural Population | 14 | 2021 | 2325 | 0.940 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2019 | 627 | 0.940 |
Why?
|
| Genetic Variation | 17 | 2019 | 6611 | 0.940 |
Why?
|
| Pesticides | 6 | 2019 | 298 | 0.920 |
Why?
|
| Prospective Studies | 78 | 2023 | 54926 | 0.910 |
Why?
|
| Arsenicals | 6 | 2019 | 117 | 0.910 |
Why?
|
| Petroleum | 10 | 2009 | 82 | 0.910 |
Why?
|
| Young Adult | 72 | 2024 | 60066 | 0.910 |
Why?
|
| Bacterial Toxins | 2 | 2020 | 922 | 0.890 |
Why?
|
| Proportional Hazards Models | 33 | 2024 | 12543 | 0.890 |
Why?
|
| Genetic Loci | 10 | 2021 | 2629 | 0.890 |
Why?
|
| Risk Assessment | 46 | 2024 | 24315 | 0.880 |
Why?
|
| Neoplasm Staging | 33 | 2024 | 11244 | 0.880 |
Why?
|
| Protoporphyria, Erythropoietic | 2 | 2022 | 54 | 0.870 |
Why?
|
| Inflammation | 21 | 2021 | 10873 | 0.870 |
Why?
|
| Massachusetts | 34 | 2021 | 8890 | 0.870 |
Why?
|
| Solvents | 9 | 2002 | 298 | 0.860 |
Why?
|
| Low Back Pain | 8 | 2006 | 990 | 0.860 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 4 | 2012 | 276 | 0.850 |
Why?
|
| Employment | 7 | 2022 | 1110 | 0.850 |
Why?
|
| Longitudinal Studies | 29 | 2024 | 14783 | 0.830 |
Why?
|
| Diacetyl | 3 | 2019 | 21 | 0.830 |
Why?
|
| Gene Expression Regulation, Neoplastic | 19 | 2020 | 8647 | 0.830 |
Why?
|
| Cadmium | 1 | 2024 | 217 | 0.830 |
Why?
|
| Aerosols | 12 | 2022 | 634 | 0.820 |
Why?
|
| Prenatal Exposure Delayed Effects | 10 | 2021 | 2538 | 0.820 |
Why?
|
| Urolithiasis | 1 | 2024 | 123 | 0.810 |
Why?
|
| Work Schedule Tolerance | 5 | 2012 | 553 | 0.810 |
Why?
|
| Microfilament Proteins | 3 | 2017 | 1133 | 0.800 |
Why?
|
| Water Pollution, Chemical | 4 | 2013 | 30 | 0.790 |
Why?
|
| Mercury | 3 | 2021 | 289 | 0.790 |
Why?
|
| Lung Diseases, Interstitial | 7 | 2024 | 940 | 0.780 |
Why?
|
| Models, Genetic | 13 | 2021 | 3447 | 0.780 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2015 | 416 | 0.780 |
Why?
|
| Accidents, Traffic | 2 | 2018 | 818 | 0.770 |
Why?
|
| Gene Dosage | 7 | 2016 | 1219 | 0.770 |
Why?
|
| Mesothelioma | 5 | 2017 | 811 | 0.770 |
Why?
|
| Time Factors | 55 | 2019 | 40218 | 0.770 |
Why?
|
| Occupational Health Services | 6 | 2003 | 149 | 0.760 |
Why?
|
| MicroRNAs | 6 | 2020 | 3803 | 0.760 |
Why?
|
| Agricultural Workers' Diseases | 3 | 2015 | 27 | 0.750 |
Why?
|
| Critical Illness | 12 | 2022 | 2756 | 0.740 |
Why?
|
| Gene Frequency | 21 | 2018 | 3623 | 0.730 |
Why?
|
| Carbon Monoxide | 4 | 2019 | 560 | 0.730 |
Why?
|
| Cacodylic Acid | 5 | 2019 | 14 | 0.720 |
Why?
|
| Regression Analysis | 32 | 2018 | 6340 | 0.720 |
Why?
|
| Infant, Newborn | 39 | 2024 | 26422 | 0.720 |
Why?
|
| Urban Population | 9 | 2016 | 2046 | 0.710 |
Why?
|
| Mutagens | 6 | 2014 | 181 | 0.700 |
Why?
|
| Sepsis | 13 | 2020 | 2608 | 0.690 |
Why?
|
| Models, Statistical | 15 | 2019 | 5107 | 0.690 |
Why?
|
| Cytochrome P-450 CYP1A1 | 6 | 2002 | 88 | 0.690 |
Why?
|
| Arylamine N-Acetyltransferase | 3 | 2010 | 87 | 0.680 |
Why?
|
| Early Detection of Cancer | 9 | 2023 | 3239 | 0.680 |
Why?
|
| Pneumoconiosis | 6 | 2003 | 32 | 0.680 |
Why?
|
| Genes, Neoplasm | 4 | 2013 | 371 | 0.670 |
Why?
|
| Genetic Association Studies | 11 | 2020 | 2744 | 0.670 |
Why?
|
| NF-kappa B p50 Subunit | 2 | 2011 | 103 | 0.670 |
Why?
|
| Ozone | 6 | 2019 | 496 | 0.660 |
Why?
|
| Pneumonia | 8 | 2021 | 2163 | 0.660 |
Why?
|
| Adolescent | 77 | 2022 | 89169 | 0.660 |
Why?
|
| Circadian Rhythm | 7 | 2017 | 2593 | 0.660 |
Why?
|
| Growth Disorders | 3 | 2019 | 635 | 0.660 |
Why?
|
| HIV Seroprevalence | 1 | 2019 | 89 | 0.660 |
Why?
|
| 5-Methylcytosine | 1 | 2020 | 147 | 0.660 |
Why?
|
| Gases | 5 | 2016 | 205 | 0.650 |
Why?
|
| Survival Rate | 23 | 2022 | 12840 | 0.650 |
Why?
|
| Vital Capacity | 14 | 2020 | 996 | 0.650 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 3 | 2010 | 89 | 0.650 |
Why?
|
| Sex Factors | 26 | 2019 | 10632 | 0.640 |
Why?
|
| Lighting | 2 | 2018 | 210 | 0.640 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2014 | 3514 | 0.630 |
Why?
|
| Vanadium | 5 | 2005 | 54 | 0.630 |
Why?
|
| Persian Gulf Syndrome | 1 | 2019 | 48 | 0.630 |
Why?
|
| Asthma | 17 | 2018 | 6291 | 0.630 |
Why?
|
| Polymerase Chain Reaction | 25 | 2011 | 6082 | 0.620 |
Why?
|
| Vitamin D | 6 | 2019 | 3311 | 0.620 |
Why?
|
| Neoplasms | 25 | 2018 | 22371 | 0.610 |
Why?
|
| Workload | 4 | 2012 | 849 | 0.610 |
Why?
|
| Premature Birth | 4 | 2021 | 1829 | 0.610 |
Why?
|
| Sphingosine | 1 | 2020 | 308 | 0.610 |
Why?
|
| Sulfur Oxides | 1 | 2018 | 7 | 0.610 |
Why?
|
| Genomics | 5 | 2020 | 5926 | 0.610 |
Why?
|
| Angiopoietin-2 | 5 | 2018 | 186 | 0.610 |
Why?
|
| Intensive Care Units | 21 | 2023 | 3800 | 0.610 |
Why?
|
| Rescue Work | 4 | 2008 | 58 | 0.600 |
Why?
|
| Body Size | 1 | 2021 | 463 | 0.600 |
Why?
|
| Lysophospholipids | 1 | 2020 | 338 | 0.600 |
Why?
|
| beta-Glucans | 1 | 2019 | 129 | 0.600 |
Why?
|
| Prevalence | 37 | 2024 | 15869 | 0.590 |
Why?
|
| Respiration Disorders | 6 | 2024 | 364 | 0.590 |
Why?
|
| Lung Injury | 2 | 2021 | 433 | 0.590 |
Why?
|
| Systemic Inflammatory Response Syndrome | 4 | 2018 | 621 | 0.590 |
Why?
|
| Nitric Oxide | 5 | 2013 | 2146 | 0.590 |
Why?
|
| Cross-Sectional Studies | 48 | 2022 | 26379 | 0.590 |
Why?
|
| Telomere | 4 | 2019 | 944 | 0.580 |
Why?
|
| Carbon Dioxide | 2 | 2019 | 1148 | 0.580 |
Why?
|
| Matrix Metalloproteinase 1 | 4 | 2009 | 147 | 0.580 |
Why?
|
| Epidermal Growth Factor | 4 | 2009 | 697 | 0.580 |
Why?
|
| Gastroesophageal Reflux | 8 | 2013 | 836 | 0.580 |
Why?
|
| Physical Fitness | 7 | 2022 | 744 | 0.570 |
Why?
|
| Safety Management | 5 | 2017 | 765 | 0.570 |
Why?
|
| Virus Diseases | 2 | 2023 | 724 | 0.570 |
Why?
|
| Skin Neoplasms | 11 | 2019 | 5863 | 0.570 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 4 | 2024 | 1767 | 0.570 |
Why?
|
| Fetal Growth Retardation | 2 | 2018 | 592 | 0.560 |
Why?
|
| Population Surveillance | 13 | 2016 | 2596 | 0.560 |
Why?
|
| Nuclear Proteins | 3 | 2022 | 5804 | 0.560 |
Why?
|
| Spinal Dysraphism | 3 | 2024 | 179 | 0.560 |
Why?
|
| Bayes Theorem | 9 | 2024 | 2359 | 0.560 |
Why?
|
| Weather | 2 | 2018 | 234 | 0.550 |
Why?
|
| Mendelian Randomization Analysis | 8 | 2021 | 1040 | 0.550 |
Why?
|
| Workplace | 10 | 2022 | 873 | 0.550 |
Why?
|
| Boston | 18 | 2024 | 9374 | 0.540 |
Why?
|
| Cause of Death | 8 | 2016 | 3721 | 0.530 |
Why?
|
| Follow-Up Studies | 38 | 2021 | 39348 | 0.520 |
Why?
|
| Workers' Compensation | 6 | 2000 | 150 | 0.520 |
Why?
|
| Volatile Organic Compounds | 1 | 2017 | 86 | 0.520 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 467 | 0.520 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2015 | 1942 | 0.510 |
Why?
|
| Marriage | 1 | 2017 | 351 | 0.510 |
Why?
|
| Gestational Age | 7 | 2019 | 3621 | 0.510 |
Why?
|
| Sleep Deprivation | 2 | 2012 | 848 | 0.500 |
Why?
|
| Multivariate Analysis | 23 | 2018 | 12077 | 0.500 |
Why?
|
| Diet | 13 | 2019 | 8089 | 0.500 |
Why?
|
| Aspartate Aminotransferases | 6 | 2014 | 414 | 0.500 |
Why?
|
| Hospital Mortality | 9 | 2016 | 5349 | 0.490 |
Why?
|
| Alcohol Drinking | 10 | 2018 | 4045 | 0.490 |
Why?
|
| Immediate-Early Proteins | 1 | 2018 | 444 | 0.490 |
Why?
|
| Diet Records | 1 | 2017 | 426 | 0.490 |
Why?
|
| Food, Preserved | 1 | 2015 | 13 | 0.490 |
Why?
|
| Cardiovascular Diseases | 14 | 2019 | 15662 | 0.490 |
Why?
|
| Pleural Diseases | 6 | 2017 | 138 | 0.490 |
Why?
|
| Receptors, Calcitriol | 2 | 2008 | 361 | 0.490 |
Why?
|
| Wounds and Injuries | 7 | 2018 | 2517 | 0.490 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2019 | 387 | 0.490 |
Why?
|
| Fatigue | 2 | 2012 | 1557 | 0.490 |
Why?
|
| Histone Demethylases | 1 | 2018 | 328 | 0.490 |
Why?
|
| Genetic Markers | 9 | 2018 | 2603 | 0.490 |
Why?
|
| Environment Design | 1 | 2016 | 174 | 0.480 |
Why?
|
| Airway Remodeling | 1 | 2016 | 133 | 0.480 |
Why?
|
| Ventricular Premature Complexes | 1 | 2016 | 112 | 0.480 |
Why?
|
| Transportation | 2 | 2015 | 217 | 0.480 |
Why?
|
| Disease Susceptibility | 9 | 2020 | 1793 | 0.480 |
Why?
|
| Neoplasms, Radiation-Induced | 3 | 2018 | 542 | 0.480 |
Why?
|
| Genome, Human | 5 | 2018 | 4446 | 0.480 |
Why?
|
| Peroxidase | 5 | 2008 | 610 | 0.480 |
Why?
|
| Codon | 8 | 2004 | 599 | 0.470 |
Why?
|
| Meat Products | 1 | 2015 | 97 | 0.470 |
Why?
|
| Airway Obstruction | 4 | 2006 | 672 | 0.460 |
Why?
|
| DNA Helicases | 4 | 2004 | 854 | 0.460 |
Why?
|
| Mutation | 22 | 2024 | 30238 | 0.460 |
Why?
|
| Silicon Dioxide | 4 | 2020 | 218 | 0.460 |
Why?
|
| Tobacco Industry | 1 | 2015 | 138 | 0.460 |
Why?
|
| Alanine Transaminase | 6 | 2014 | 606 | 0.460 |
Why?
|
| Breath Tests | 5 | 2014 | 300 | 0.460 |
Why?
|
| Critical Care | 9 | 2019 | 2715 | 0.460 |
Why?
|
| Incidence | 26 | 2023 | 21538 | 0.460 |
Why?
|
| Kaplan-Meier Estimate | 15 | 2021 | 6526 | 0.450 |
Why?
|
| Nuclear Weapons | 1 | 2014 | 12 | 0.450 |
Why?
|
| Neuroendocrine Tumors | 6 | 2017 | 659 | 0.450 |
Why?
|
| Bronchitis | 6 | 2010 | 194 | 0.450 |
Why?
|
| RNA, Ribosomal, 16S | 2 | 2017 | 1049 | 0.450 |
Why?
|
| Methyltransferases | 2 | 2019 | 373 | 0.450 |
Why?
|
| Acute Kidney Injury | 6 | 2019 | 1942 | 0.450 |
Why?
|
| Proteins | 12 | 2023 | 6009 | 0.440 |
Why?
|
| Pregnancy Outcome | 4 | 2019 | 2972 | 0.440 |
Why?
|
| Proteomics | 5 | 2020 | 3912 | 0.440 |
Why?
|
| Promoter Regions, Genetic | 12 | 2014 | 5797 | 0.440 |
Why?
|
| Maternal Welfare | 1 | 2014 | 113 | 0.440 |
Why?
|
| Vibration | 3 | 2005 | 335 | 0.440 |
Why?
|
| Infant | 36 | 2024 | 36535 | 0.440 |
Why?
|
| Obesity | 18 | 2021 | 13090 | 0.430 |
Why?
|
| Disease-Free Survival | 15 | 2019 | 6847 | 0.430 |
Why?
|
| Receptors, Cell Surface | 3 | 2018 | 2819 | 0.430 |
Why?
|
| Age Factors | 27 | 2021 | 18412 | 0.430 |
Why?
|
| Insect Proteins | 4 | 2003 | 253 | 0.430 |
Why?
|
| DNA Copy Number Variations | 2 | 2019 | 2048 | 0.430 |
Why?
|
| Vinyl Chloride | 3 | 2010 | 15 | 0.430 |
Why?
|
| Residence Characteristics | 4 | 2020 | 2118 | 0.430 |
Why?
|
| Adiponectin | 3 | 2020 | 1117 | 0.420 |
Why?
|
| Apoptosis | 9 | 2022 | 9523 | 0.420 |
Why?
|
| Tomography, X-Ray Computed | 18 | 2024 | 20760 | 0.420 |
Why?
|
| Receptor, Notch2 | 1 | 2013 | 90 | 0.420 |
Why?
|
| Helicobacter Infections | 2 | 2014 | 390 | 0.420 |
Why?
|
| Polymorphism, Restriction Fragment Length | 10 | 2004 | 766 | 0.420 |
Why?
|
| Spacecraft | 1 | 2012 | 28 | 0.420 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2015 | 414 | 0.420 |
Why?
|
| Linkage Disequilibrium | 12 | 2018 | 1997 | 0.420 |
Why?
|
| Pulmonary Emphysema | 2 | 2015 | 689 | 0.410 |
Why?
|
| Sequence Analysis, DNA | 4 | 2017 | 4786 | 0.410 |
Why?
|
| Analysis of Variance | 19 | 2016 | 6229 | 0.410 |
Why?
|
| APACHE | 8 | 2015 | 268 | 0.410 |
Why?
|
| Leukocyte Elastase | 2 | 2014 | 114 | 0.410 |
Why?
|
| Silicosis | 3 | 2008 | 47 | 0.410 |
Why?
|
| Interleukin-6 | 7 | 2018 | 3228 | 0.410 |
Why?
|
| Environment | 3 | 2018 | 1121 | 0.400 |
Why?
|
| C-Reactive Protein | 9 | 2023 | 3858 | 0.400 |
Why?
|
| Free Radical Scavengers | 2 | 2003 | 213 | 0.400 |
Why?
|
| Phenotype | 16 | 2020 | 16726 | 0.400 |
Why?
|
| Tomography, Spiral Computed | 1 | 2014 | 273 | 0.400 |
Why?
|
| Respiratory Sounds | 2 | 2015 | 702 | 0.400 |
Why?
|
| Genes, bcl-2 | 1 | 2012 | 119 | 0.400 |
Why?
|
| Mouth Neoplasms | 1 | 2017 | 597 | 0.400 |
Why?
|
| Anemia | 3 | 2018 | 1514 | 0.400 |
Why?
|
| Bronchial Hyperreactivity | 3 | 2012 | 301 | 0.390 |
Why?
|
| Environmental Illness | 1 | 2012 | 33 | 0.390 |
Why?
|
| Child Development | 4 | 2018 | 2330 | 0.390 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 1143 | 0.390 |
Why?
|
| Light | 1 | 2018 | 1355 | 0.390 |
Why?
|
| Vehicle Emissions | 6 | 2018 | 651 | 0.390 |
Why?
|
| Confidence Intervals | 14 | 2012 | 2923 | 0.390 |
Why?
|
| Pulmonary Medicine | 3 | 2019 | 223 | 0.390 |
Why?
|
| gamma-Glutamyltransferase | 4 | 2014 | 144 | 0.380 |
Why?
|
| Hair | 1 | 2015 | 508 | 0.380 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2013 | 514 | 0.380 |
Why?
|
| Remote Sensing Technology | 1 | 2012 | 93 | 0.380 |
Why?
|
| Principal Component Analysis | 4 | 2014 | 948 | 0.380 |
Why?
|
| Urinary Bladder Neoplasms | 5 | 2008 | 2195 | 0.380 |
Why?
|
| Food Contamination | 2 | 2017 | 193 | 0.380 |
Why?
|
| Contact Tracing | 1 | 2014 | 275 | 0.380 |
Why?
|
| Nitrosamines | 1 | 2011 | 86 | 0.380 |
Why?
|
| Fas Ligand Protein | 2 | 2008 | 216 | 0.370 |
Why?
|
| Micronuclei, Chromosome-Defective | 2 | 2010 | 37 | 0.370 |
Why?
|
| Tuberculosis, Pulmonary | 2 | 2017 | 843 | 0.370 |
Why?
|
| Likelihood Functions | 6 | 2017 | 994 | 0.370 |
Why?
|
| Radiation Pneumonitis | 1 | 2011 | 100 | 0.370 |
Why?
|
| Angiogenic Proteins | 1 | 2011 | 101 | 0.370 |
Why?
|
| Heating | 4 | 2012 | 104 | 0.370 |
Why?
|
| Peritoneal Neoplasms | 1 | 2017 | 714 | 0.360 |
Why?
|
| Vitamins | 1 | 2019 | 1638 | 0.360 |
Why?
|
| Quantitative Trait Loci | 14 | 2022 | 2131 | 0.360 |
Why?
|
| Zinc | 6 | 2021 | 677 | 0.360 |
Why?
|
| United States | 44 | 2024 | 73039 | 0.360 |
Why?
|
| Interleukin-10 | 4 | 2016 | 1183 | 0.360 |
Why?
|
| Mexico | 5 | 2018 | 769 | 0.350 |
Why?
|
| Computational Biology | 5 | 2020 | 3568 | 0.350 |
Why?
|
| Herbicides | 3 | 2000 | 104 | 0.350 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2013 | 542 | 0.350 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2012 | 1854 | 0.350 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 11928 | 0.350 |
Why?
|
| Pleural Neoplasms | 3 | 2004 | 612 | 0.350 |
Why?
|
| Barrett Esophagus | 2 | 2012 | 495 | 0.350 |
Why?
|
| Chromosomes, Human, Pair 15 | 3 | 2018 | 361 | 0.350 |
Why?
|
| Mass Spectrometry | 7 | 2012 | 2202 | 0.350 |
Why?
|
| Matrix Metalloproteinase 3 | 3 | 2009 | 139 | 0.340 |
Why?
|
| Sunburn | 2 | 2010 | 156 | 0.340 |
Why?
|
| Neoplasm Proteins | 4 | 2019 | 3603 | 0.340 |
Why?
|
| Bronchiectasis | 2 | 2022 | 141 | 0.330 |
Why?
|
| Genetics, Population | 2 | 2012 | 944 | 0.330 |
Why?
|
| GTP Phosphohydrolase Activators | 1 | 2009 | 4 | 0.330 |
Why?
|
| Algorithms | 17 | 2024 | 14164 | 0.330 |
Why?
|
| Child, Preschool | 32 | 2019 | 42669 | 0.330 |
Why?
|
| Estrogen Receptor beta | 1 | 2010 | 171 | 0.330 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2019 | 1399 | 0.330 |
Why?
|
| Long Interspersed Nucleotide Elements | 4 | 2023 | 332 | 0.330 |
Why?
|
| Epidemiologic Research Design | 1 | 2012 | 368 | 0.320 |
Why?
|
| Bronchoalveolar Lavage Fluid | 11 | 2012 | 760 | 0.320 |
Why?
|
| Data Interpretation, Statistical | 7 | 2020 | 2709 | 0.320 |
Why?
|
| Hyperbilirubinemia | 1 | 2009 | 74 | 0.320 |
Why?
|
| Mutation, Missense | 2 | 2017 | 2592 | 0.320 |
Why?
|
| Methylation | 5 | 2019 | 1078 | 0.320 |
Why?
|
| Carrier Proteins | 4 | 2019 | 4937 | 0.320 |
Why?
|
| RGS Proteins | 1 | 2009 | 76 | 0.320 |
Why?
|
| Interleukin-1beta | 3 | 2014 | 1027 | 0.320 |
Why?
|
| Cyclins | 2 | 2019 | 606 | 0.310 |
Why?
|
| Sex Distribution | 7 | 2014 | 2278 | 0.310 |
Why?
|
| Illinois | 2 | 2019 | 120 | 0.310 |
Why?
|
| Pulmonary Surfactant-Associated Protein B | 1 | 2008 | 44 | 0.310 |
Why?
|
| Carcinoma, Transitional Cell | 3 | 2005 | 794 | 0.310 |
Why?
|
| Blood Pressure | 12 | 2022 | 8543 | 0.310 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 11 | 2021 | 3800 | 0.310 |
Why?
|
| Hypertension | 12 | 2021 | 8616 | 0.310 |
Why?
|
| Matrix Metalloproteinases | 2 | 2012 | 393 | 0.310 |
Why?
|
| Korea | 8 | 2003 | 97 | 0.310 |
Why?
|
| Acceleration | 3 | 2017 | 189 | 0.300 |
Why?
|
| Xenobiotics | 2 | 2008 | 71 | 0.300 |
Why?
|
| Pleura | 4 | 2017 | 248 | 0.300 |
Why?
|
| Survivors | 2 | 2021 | 2381 | 0.300 |
Why?
|
| Pregnancy Trimester, First | 4 | 2016 | 917 | 0.300 |
Why?
|
| Arginine | 6 | 2009 | 932 | 0.300 |
Why?
|
| Myocardium | 3 | 2012 | 4788 | 0.300 |
Why?
|
| Cough | 5 | 2010 | 598 | 0.300 |
Why?
|
| Heart Diseases | 4 | 2015 | 2819 | 0.300 |
Why?
|
| Blood Platelets | 1 | 2019 | 2479 | 0.300 |
Why?
|
| Microsatellite Repeats | 3 | 2009 | 785 | 0.300 |
Why?
|
| Autonomic Nervous System Diseases | 1 | 2010 | 270 | 0.300 |
Why?
|
| Shock, Septic | 2 | 2012 | 774 | 0.300 |
Why?
|
| Sister Chromatid Exchange | 8 | 2000 | 60 | 0.300 |
Why?
|
| Norway | 5 | 2018 | 501 | 0.300 |
Why?
|
| Tumor Suppressor Proteins | 1 | 2018 | 2810 | 0.290 |
Why?
|
| Health Surveys | 8 | 2016 | 4057 | 0.290 |
Why?
|
| Infant Mortality | 3 | 2019 | 752 | 0.290 |
Why?
|
| Dinoprost | 1 | 2008 | 139 | 0.290 |
Why?
|
| Reactive Oxygen Species | 2 | 2014 | 2149 | 0.290 |
Why?
|
| Severity of Illness Index | 16 | 2020 | 15948 | 0.290 |
Why?
|
| DNA-(Apurinic or Apyrimidinic Site) Lyase | 1 | 2007 | 72 | 0.290 |
Why?
|
| Disease Progression | 9 | 2022 | 13671 | 0.290 |
Why?
|
| Trace Elements | 2 | 2019 | 193 | 0.280 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2011 | 452 | 0.280 |
Why?
|
| Nasal Lavage Fluid | 3 | 1998 | 17 | 0.280 |
Why?
|
| Bilirubin | 1 | 2009 | 438 | 0.280 |
Why?
|
| Sulfur Dioxide | 4 | 2003 | 178 | 0.280 |
Why?
|
| Insecticides | 4 | 2002 | 200 | 0.280 |
Why?
|
| Troponin T | 1 | 2012 | 787 | 0.280 |
Why?
|
| Receptor, TIE-2 | 3 | 2018 | 183 | 0.280 |
Why?
|
| Cooking | 3 | 2022 | 327 | 0.280 |
Why?
|
| Uganda | 7 | 2022 | 1361 | 0.280 |
Why?
|
| Muscle Proteins | 1 | 2012 | 1165 | 0.280 |
Why?
|
| Tumor Necrosis Factor-alpha | 5 | 2019 | 4352 | 0.280 |
Why?
|
| Respiratory Insufficiency | 1 | 2016 | 1240 | 0.280 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2023 | 12252 | 0.280 |
Why?
|
| Tumor Necrosis Factors | 1 | 2007 | 109 | 0.280 |
Why?
|
| Cyclin D1 | 1 | 2009 | 453 | 0.280 |
Why?
|
| Mass Screening | 7 | 2023 | 5458 | 0.280 |
Why?
|
| Sarcoidosis | 1 | 2012 | 535 | 0.280 |
Why?
|
| Gene Regulatory Networks | 5 | 2018 | 1752 | 0.280 |
Why?
|
| Cognition | 4 | 2020 | 7073 | 0.270 |
Why?
|
| Recovery of Function | 2 | 2015 | 2981 | 0.270 |
Why?
|
| Social Class | 1 | 2016 | 2008 | 0.270 |
Why?
|
| Heme Oxygenase-1 | 1 | 2009 | 364 | 0.270 |
Why?
|
| Chronic Disease | 16 | 2019 | 9384 | 0.270 |
Why?
|
| Reference Values | 13 | 2013 | 4938 | 0.270 |
Why?
|
| Tumor Suppressor Protein p53 | 5 | 2022 | 2954 | 0.270 |
Why?
|
| Chromosomes | 1 | 2010 | 578 | 0.270 |
Why?
|
| Pneumonectomy | 1 | 2014 | 1156 | 0.270 |
Why?
|
| Carcinoma, Small Cell | 3 | 2005 | 419 | 0.270 |
Why?
|
| Parity | 1 | 2010 | 931 | 0.270 |
Why?
|
| Acetoin | 2 | 2016 | 5 | 0.270 |
Why?
|
| Government Regulation | 1 | 2011 | 525 | 0.270 |
Why?
|
| Random Allocation | 5 | 2018 | 2396 | 0.270 |
Why?
|
| DNA, Mitochondrial | 4 | 2016 | 872 | 0.270 |
Why?
|
| Pentanones | 2 | 2016 | 12 | 0.270 |
Why?
|
| Areca | 1 | 2006 | 11 | 0.270 |
Why?
|
| Epidemiologic Studies | 7 | 2018 | 677 | 0.270 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2008 | 299 | 0.270 |
Why?
|
| I-kappa B Proteins | 1 | 2007 | 210 | 0.260 |
Why?
|
| Socioeconomic Factors | 11 | 2019 | 7852 | 0.260 |
Why?
|
| Bacteria | 1 | 2017 | 2216 | 0.260 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 1613 | 0.260 |
Why?
|
| Carboxyhemoglobin | 3 | 1995 | 83 | 0.260 |
Why?
|
| Bronchi | 2 | 2021 | 850 | 0.260 |
Why?
|
| Child | 32 | 2022 | 80917 | 0.260 |
Why?
|
| Transcription Factor RelA | 1 | 2007 | 252 | 0.260 |
Why?
|
| Mannose-Binding Lectin | 1 | 2007 | 146 | 0.250 |
Why?
|
| Hemoglobins | 2 | 2016 | 1531 | 0.250 |
Why?
|
| Women's Health | 2 | 2013 | 2082 | 0.250 |
Why?
|
| Retrospective Studies | 26 | 2024 | 81762 | 0.250 |
Why?
|
| Leukemia | 4 | 2008 | 1519 | 0.250 |
Why?
|
| Esterases | 2 | 2003 | 89 | 0.250 |
Why?
|
| Creatine Kinase | 1 | 2007 | 684 | 0.250 |
Why?
|
| Weight Gain | 1 | 2016 | 2359 | 0.250 |
Why?
|
| Homozygote | 10 | 2017 | 1779 | 0.250 |
Why?
|
| Signal Transduction | 12 | 2021 | 23645 | 0.250 |
Why?
|
| Lymphotoxin-alpha | 1 | 2005 | 94 | 0.250 |
Why?
|
| Receptors, Adiponectin | 3 | 2020 | 82 | 0.250 |
Why?
|
| Positron-Emission Tomography | 1 | 2022 | 6669 | 0.250 |
Why?
|
| Area Under Curve | 2 | 2021 | 1643 | 0.250 |
Why?
|
| Papillomavirus Infections | 2 | 2009 | 1640 | 0.240 |
Why?
|
| Blood | 1 | 2008 | 599 | 0.240 |
Why?
|
| Sciatica | 1 | 2005 | 97 | 0.240 |
Why?
|
| Vasoconstriction | 1 | 2008 | 592 | 0.240 |
Why?
|
| Brassica | 1 | 2004 | 39 | 0.240 |
Why?
|
| Cytokines | 5 | 2021 | 7453 | 0.240 |
Why?
|
| Cholesterol, HDL | 2 | 2011 | 1820 | 0.240 |
Why?
|
| Chi-Square Distribution | 7 | 2011 | 3436 | 0.240 |
Why?
|
| Phenanthrenes | 1 | 2005 | 65 | 0.240 |
Why?
|
| Chickenpox | 1 | 2005 | 95 | 0.240 |
Why?
|
| Interleukin-1 | 1 | 2008 | 1252 | 0.240 |
Why?
|
| Printing | 2 | 1997 | 47 | 0.240 |
Why?
|
| Iron, Dietary | 1 | 2005 | 148 | 0.240 |
Why?
|
| Radiotherapy | 1 | 2011 | 1502 | 0.240 |
Why?
|
| Seasons | 6 | 2017 | 1524 | 0.240 |
Why?
|
| Gene Expression | 6 | 2017 | 7598 | 0.240 |
Why?
|
| Mortality | 3 | 2020 | 2911 | 0.240 |
Why?
|
| Transcription Factors | 6 | 2024 | 12168 | 0.240 |
Why?
|
| Collagen Type IX | 1 | 2004 | 20 | 0.230 |
Why?
|
| Electrocardiography | 7 | 2017 | 6412 | 0.230 |
Why?
|
| Antimony | 1 | 2004 | 20 | 0.230 |
Why?
|
| Job Satisfaction | 3 | 2017 | 548 | 0.230 |
Why?
|
| Coal Mining | 2 | 2002 | 12 | 0.230 |
Why?
|
| Metalloendopeptidases | 2 | 2005 | 386 | 0.230 |
Why?
|
| Epidemiologic Methods | 9 | 2009 | 1328 | 0.230 |
Why?
|
| Sperm Count | 5 | 2003 | 228 | 0.230 |
Why?
|
| Labor Unions | 2 | 2014 | 50 | 0.230 |
Why?
|
| Antineoplastic Agents | 8 | 2015 | 13676 | 0.230 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2002 | 235 | 0.230 |
Why?
|
| Silk | 5 | 2007 | 93 | 0.220 |
Why?
|
| Dietary Supplements | 3 | 2019 | 3445 | 0.220 |
Why?
|
| Troponin | 1 | 2007 | 535 | 0.220 |
Why?
|
| Interleukin-8 | 3 | 2016 | 704 | 0.220 |
Why?
|
| Spermatozoa | 4 | 2003 | 632 | 0.220 |
Why?
|
| Paternal Exposure | 1 | 2004 | 100 | 0.220 |
Why?
|
| RNA, Messenger | 12 | 2021 | 12800 | 0.220 |
Why?
|
| Lumbosacral Region | 1 | 2005 | 294 | 0.220 |
Why?
|
| Quinone Reductases | 2 | 2001 | 24 | 0.220 |
Why?
|
| Carcinoma | 2 | 2023 | 2332 | 0.220 |
Why?
|
| Incineration | 2 | 2021 | 21 | 0.220 |
Why?
|
| Nose | 2 | 2017 | 522 | 0.220 |
Why?
|
| Habits | 1 | 2024 | 148 | 0.220 |
Why?
|
| Genetic Pleiotropy | 2 | 2016 | 181 | 0.220 |
Why?
|
| Reproducibility of Results | 17 | 2021 | 20227 | 0.220 |
Why?
|
| Age of Onset | 2 | 2011 | 3347 | 0.220 |
Why?
|
| Stomach Neoplasms | 1 | 2014 | 1481 | 0.220 |
Why?
|
| Occupational Medicine | 5 | 2002 | 116 | 0.210 |
Why?
|
| Rural Health | 3 | 2019 | 302 | 0.210 |
Why?
|
| Liver | 5 | 2001 | 7577 | 0.210 |
Why?
|
| DNA | 6 | 2016 | 7214 | 0.210 |
Why?
|
| Quinazolines | 2 | 2007 | 1373 | 0.210 |
Why?
|
| Emergencies | 2 | 2007 | 1221 | 0.210 |
Why?
|
| Macrophages, Alveolar | 5 | 2003 | 415 | 0.210 |
Why?
|
| Asia | 3 | 2020 | 629 | 0.210 |
Why?
|
| Platinum | 1 | 2004 | 222 | 0.210 |
Why?
|
| Acute Disease | 7 | 2015 | 7243 | 0.210 |
Why?
|
| Environmental Health | 3 | 2018 | 298 | 0.210 |
Why?
|
| Arteries | 1 | 2008 | 1127 | 0.210 |
Why?
|
| Wisconsin | 2 | 2019 | 122 | 0.210 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3238 | 0.210 |
Why?
|
| Water | 2 | 2007 | 1421 | 0.210 |
Why?
|
| Valine | 2 | 2019 | 410 | 0.210 |
Why?
|
| Spondylolisthesis | 1 | 2004 | 173 | 0.210 |
Why?
|
| Marketing of Health Services | 1 | 2004 | 151 | 0.210 |
Why?
|
| Pulmonary Surfactants | 1 | 2023 | 169 | 0.210 |
Why?
|
| Hypersensitivity, Immediate | 2 | 2003 | 349 | 0.210 |
Why?
|
| Irritants | 2 | 2004 | 43 | 0.210 |
Why?
|
| Coronary Disease | 4 | 2012 | 5919 | 0.200 |
Why?
|
| Calcium, Dietary | 1 | 2005 | 533 | 0.200 |
Why?
|
| Noise, Occupational | 2 | 2001 | 26 | 0.200 |
Why?
|
| Hospitalization | 5 | 2023 | 10840 | 0.200 |
Why?
|
| Amino Acid Substitution | 1 | 2007 | 1743 | 0.200 |
Why?
|
| Benzene Derivatives | 2 | 2001 | 51 | 0.200 |
Why?
|
| Cluster Analysis | 5 | 2019 | 2732 | 0.200 |
Why?
|
| Vegetables | 3 | 2009 | 1199 | 0.200 |
Why?
|
| Vanadium Compounds | 3 | 1998 | 8 | 0.200 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2015 | 2892 | 0.200 |
Why?
|
| Sigmoid Neoplasms | 1 | 2022 | 54 | 0.200 |
Why?
|
| Glypicans | 2 | 2014 | 33 | 0.200 |
Why?
|
| Hazardous Waste | 1 | 2001 | 23 | 0.200 |
Why?
|
| Tryptophan | 1 | 2004 | 482 | 0.200 |
Why?
|
| Protective Clothing | 2 | 1999 | 103 | 0.200 |
Why?
|
| Europe | 5 | 2020 | 3436 | 0.200 |
Why?
|
| N-Glycosyl Hydrolases | 1 | 2002 | 68 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2012 | 1406 | 0.200 |
Why?
|
| Methacholine Chloride | 5 | 2003 | 220 | 0.200 |
Why?
|
| Chromosome Mapping | 7 | 2018 | 4620 | 0.200 |
Why?
|
| Posture | 2 | 2005 | 957 | 0.200 |
Why?
|
| Internationality | 3 | 2018 | 1008 | 0.190 |
Why?
|
| Predictive Value of Tests | 11 | 2021 | 15454 | 0.190 |
Why?
|
| Ovarian Neoplasms | 4 | 2023 | 4916 | 0.190 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 2002 | 85 | 0.190 |
Why?
|
| Carcinogenicity Tests | 2 | 2018 | 39 | 0.190 |
Why?
|
| Polycyclic Compounds | 2 | 1999 | 28 | 0.190 |
Why?
|
| Specialization | 1 | 2006 | 779 | 0.190 |
Why?
|
| Membrane Proteins | 6 | 2019 | 7876 | 0.190 |
Why?
|
| Pilot Projects | 8 | 2022 | 8741 | 0.190 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3409 | 0.190 |
Why?
|
| Organic Chemicals | 1 | 2002 | 211 | 0.190 |
Why?
|
| Age Distribution | 5 | 2012 | 2873 | 0.190 |
Why?
|
| Databases, Genetic | 2 | 2019 | 1758 | 0.180 |
Why?
|
| Research | 4 | 2016 | 1979 | 0.180 |
Why?
|
| Models, Theoretical | 5 | 2019 | 3573 | 0.180 |
Why?
|
| Hematologic Diseases | 2 | 2005 | 498 | 0.180 |
Why?
|
| Urban Health | 3 | 2012 | 535 | 0.180 |
Why?
|
| Health Behavior | 2 | 2003 | 2650 | 0.180 |
Why?
|
| Health Status Disparities | 1 | 2013 | 1885 | 0.180 |
Why?
|
| Gene Amplification | 5 | 2012 | 1095 | 0.180 |
Why?
|
| Caspase 7 | 2 | 2011 | 51 | 0.180 |
Why?
|
| Inositol 1,4,5-Trisphosphate Receptors | 1 | 2021 | 89 | 0.180 |
Why?
|
| Meta-Analysis as Topic | 4 | 2016 | 1363 | 0.180 |
Why?
|
| Pharmacogenetics | 3 | 2010 | 683 | 0.180 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2010 | 2258 | 0.180 |
Why?
|
| Sensitivity and Specificity | 14 | 2007 | 14729 | 0.180 |
Why?
|
| Benzoic Acid | 1 | 2000 | 16 | 0.180 |
Why?
|
| Hippurates | 1 | 2000 | 15 | 0.180 |
Why?
|
| Ferrochelatase | 1 | 2020 | 47 | 0.180 |
Why?
|
| Cities | 3 | 2015 | 543 | 0.180 |
Why?
|
| Biological Specimen Banks | 3 | 2023 | 788 | 0.180 |
Why?
|
| Private Sector | 1 | 2004 | 396 | 0.180 |
Why?
|
| Toluene | 1 | 2000 | 34 | 0.180 |
Why?
|
| DNA Primers | 8 | 2010 | 2828 | 0.180 |
Why?
|
| Industrial Waste | 1 | 2000 | 24 | 0.180 |
Why?
|
| Cytosine | 1 | 2001 | 213 | 0.180 |
Why?
|
| Health Promotion | 2 | 2003 | 2210 | 0.180 |
Why?
|
| Gasoline | 2 | 2018 | 49 | 0.180 |
Why?
|
| Guanine | 1 | 2001 | 280 | 0.170 |
Why?
|
| Automobiles | 4 | 2011 | 103 | 0.170 |
Why?
|
| Alkanesulfonic Acids | 1 | 2023 | 203 | 0.170 |
Why?
|
| Fibronectins | 2 | 2014 | 722 | 0.170 |
Why?
|
| Models, Chemical | 2 | 2012 | 611 | 0.170 |
Why?
|
| 5' Untranslated Regions | 1 | 2001 | 255 | 0.170 |
Why?
|
| European Union | 2 | 2018 | 158 | 0.170 |
Why?
|
| Liver Function Tests | 5 | 2001 | 526 | 0.170 |
Why?
|
| Erythrocyte Transfusion | 1 | 2005 | 575 | 0.170 |
Why?
|
| Geographic Information Systems | 2 | 2016 | 283 | 0.170 |
Why?
|
| Emergency Treatment | 1 | 2004 | 497 | 0.170 |
Why?
|
| Influenza, Human | 1 | 2011 | 1541 | 0.170 |
Why?
|
| Patient Care | 1 | 2005 | 629 | 0.170 |
Why?
|
| Folic Acid Deficiency | 2 | 2019 | 117 | 0.170 |
Why?
|
| Statistics, Nonparametric | 5 | 2017 | 2862 | 0.170 |
Why?
|
| Head and Neck Neoplasms | 3 | 2019 | 2931 | 0.170 |
Why?
|
| Self Report | 4 | 2018 | 3773 | 0.170 |
Why?
|
| Crohn Disease | 1 | 2012 | 2295 | 0.170 |
Why?
|
| Epithelial Cells | 3 | 2021 | 3703 | 0.170 |
Why?
|
| Healthy Worker Effect | 3 | 2013 | 28 | 0.170 |
Why?
|
| Genetic Testing | 3 | 2015 | 3591 | 0.170 |
Why?
|
| Diphtheria-Tetanus Vaccine | 1 | 2019 | 3 | 0.170 |
Why?
|
| Respiratory System | 1 | 2003 | 564 | 0.170 |
Why?
|
| Carbon Monoxide Poisoning | 2 | 2004 | 65 | 0.170 |
Why?
|
| Insulin-Like Growth Factor Binding Proteins | 1 | 2020 | 208 | 0.170 |
Why?
|
| Hearing Loss, Noise-Induced | 1 | 2001 | 144 | 0.170 |
Why?
|
| Musculoskeletal Diseases | 1 | 2005 | 599 | 0.170 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 7 | 2013 | 3814 | 0.170 |
Why?
|
| Natriuretic Peptide, Brain | 1 | 2008 | 1751 | 0.170 |
Why?
|
| Paraquat | 1 | 1999 | 36 | 0.160 |
Why?
|
| Matrix Metalloproteinase 12 | 3 | 2009 | 44 | 0.160 |
Why?
|
| Neural Stem Cells | 2 | 2017 | 895 | 0.160 |
Why?
|
| Molecular Epidemiology | 3 | 2009 | 473 | 0.160 |
Why?
|
| Bronchitis, Chronic | 2 | 2010 | 82 | 0.160 |
Why?
|
| Adenosylmethionine Decarboxylase | 1 | 2019 | 11 | 0.160 |
Why?
|
| Mineral Fibers | 1 | 1999 | 26 | 0.160 |
Why?
|
| Toll-Like Receptors | 2 | 2018 | 582 | 0.160 |
Why?
|
| Pyridines | 1 | 2011 | 2894 | 0.160 |
Why?
|
| Hypertriglyceridemia | 1 | 2002 | 293 | 0.160 |
Why?
|
| Multiple Organ Failure | 1 | 2022 | 388 | 0.160 |
Why?
|
| Site-Specific DNA-Methyltransferase (Adenine-Specific) | 1 | 2019 | 18 | 0.160 |
Why?
|
| Fetal Mortality | 1 | 2019 | 19 | 0.160 |
Why?
|
| Ribosomal Proteins | 1 | 2021 | 369 | 0.160 |
Why?
|
| Fruit | 3 | 2016 | 1165 | 0.160 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2016 | 4528 | 0.160 |
Why?
|
| Fellowships and Scholarships | 2 | 2019 | 1135 | 0.160 |
Why?
|
| Serine | 1 | 2003 | 831 | 0.160 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2019 | 58 | 0.160 |
Why?
|
| Ethylene Oxide | 3 | 1996 | 28 | 0.160 |
Why?
|
| Alanine | 1 | 2001 | 614 | 0.160 |
Why?
|
| NF-kappa B | 2 | 2007 | 2493 | 0.160 |
Why?
|
| Capillary Permeability | 3 | 2016 | 772 | 0.160 |
Why?
|
| HIV Infections | 4 | 2022 | 17569 | 0.160 |
Why?
|
| Platelet Function Tests | 1 | 2020 | 275 | 0.160 |
Why?
|
| Uncertainty | 1 | 2024 | 769 | 0.160 |
Why?
|
| Receptors, Leptin | 2 | 2010 | 352 | 0.160 |
Why?
|
| Urine | 4 | 2007 | 362 | 0.160 |
Why?
|
| Aviation | 1 | 2019 | 49 | 0.160 |
Why?
|
| Hypertrophy, Left Ventricular | 2 | 2016 | 856 | 0.160 |
Why?
|
| Methionine Sulfoxide Reductases | 1 | 2019 | 77 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2007 | 1681 | 0.150 |
Why?
|
| North Dakota | 1 | 2018 | 14 | 0.150 |
Why?
|
| Fuzzy Logic | 1 | 2018 | 58 | 0.150 |
Why?
|
| INDEL Mutation | 1 | 2019 | 267 | 0.150 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2021 | 3780 | 0.150 |
Why?
|
| Telomerase | 3 | 2019 | 751 | 0.150 |
Why?
|
| Fever | 2 | 1998 | 1614 | 0.150 |
Why?
|
| Cardiovascular Physiological Phenomena | 1 | 2000 | 241 | 0.150 |
Why?
|
| Creatinine | 2 | 2016 | 1918 | 0.150 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 1 | 2018 | 75 | 0.150 |
Why?
|
| Deoxyribonuclease I | 1 | 2019 | 228 | 0.150 |
Why?
|
| Peptidyl-Dipeptidase A | 1 | 2020 | 325 | 0.150 |
Why?
|
| Genetics, Medical | 1 | 2001 | 334 | 0.150 |
Why?
|
| Environmental Pollution | 3 | 2016 | 125 | 0.150 |
Why?
|
| Respiratory Mechanics | 4 | 2001 | 721 | 0.150 |
Why?
|
| Brazil | 3 | 2015 | 1250 | 0.150 |
Why?
|
| Papillomaviridae | 1 | 2004 | 1140 | 0.150 |
Why?
|
| Missouri | 1 | 2018 | 113 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 3 | 3 | 2009 | 323 | 0.150 |
Why?
|
| Motor Skills | 2 | 2018 | 523 | 0.150 |
Why?
|
| New York City | 2 | 2016 | 737 | 0.150 |
Why?
|
| Helicobacter pylori | 2 | 2014 | 380 | 0.150 |
Why?
|
| Selectins | 1 | 2018 | 101 | 0.150 |
Why?
|
| Phenols | 2 | 2016 | 526 | 0.150 |
Why?
|
| Sleep Medicine Specialty | 1 | 2019 | 72 | 0.150 |
Why?
|
| Point Mutation | 2 | 2002 | 1596 | 0.150 |
Why?
|
| Volatilization | 2 | 2017 | 76 | 0.150 |
Why?
|
| Chromosome Aberrations | 3 | 2018 | 1778 | 0.150 |
Why?
|
| Poisson Distribution | 4 | 2014 | 506 | 0.150 |
Why?
|
| Mouth | 2 | 2017 | 383 | 0.150 |
Why?
|
| Vitamin A | 3 | 2017 | 611 | 0.150 |
Why?
|
| Medicine | 1 | 2006 | 945 | 0.150 |
Why?
|
| Animal Technicians | 1 | 2017 | 7 | 0.150 |
Why?
|
| Elements | 1 | 2017 | 20 | 0.140 |
Why?
|
| Ribonucleases | 1 | 1998 | 266 | 0.140 |
Why?
|
| Treatment Outcome | 18 | 2017 | 65371 | 0.140 |
Why?
|
| Hypersensitivity | 3 | 2018 | 1172 | 0.140 |
Why?
|
| Genes, ras | 7 | 2007 | 663 | 0.140 |
Why?
|
| Air | 2 | 2018 | 187 | 0.140 |
Why?
|
| New England | 6 | 2021 | 1058 | 0.140 |
Why?
|
| Kerosene | 1 | 2017 | 15 | 0.140 |
Why?
|
| Arsenites | 3 | 2012 | 65 | 0.140 |
Why?
|
| Vasopressins | 1 | 2019 | 358 | 0.140 |
Why?
|
| Work | 2 | 2015 | 195 | 0.140 |
Why?
|
| India | 2 | 2019 | 2334 | 0.140 |
Why?
|
| Placenta | 2 | 2018 | 1725 | 0.140 |
Why?
|
| Models, Biological | 4 | 2015 | 9495 | 0.140 |
Why?
|
| Menthol | 1 | 2017 | 26 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2023 | 506 | 0.140 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 1 | 2024 | 1232 | 0.140 |
Why?
|
| Biomedical Research | 2 | 2015 | 3463 | 0.140 |
Why?
|
| Deductibles and Coinsurance | 1 | 2020 | 315 | 0.140 |
Why?
|
| Laurates | 1 | 2016 | 7 | 0.140 |
Why?
|
| Japan | 2 | 2019 | 1418 | 0.140 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 2018 | 187 | 0.140 |
Why?
|
| Nausea | 2 | 2014 | 682 | 0.140 |
Why?
|
| Glutamine | 4 | 2019 | 577 | 0.140 |
Why?
|
| Trauma Severity Indices | 2 | 2018 | 479 | 0.140 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 3 | 2011 | 505 | 0.140 |
Why?
|
| Scavenger Receptors, Class A | 1 | 2017 | 52 | 0.140 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2019 | 348 | 0.140 |
Why?
|
| Insulin Resistance | 4 | 2023 | 3986 | 0.140 |
Why?
|
| Radon | 1 | 2018 | 91 | 0.140 |
Why?
|
| Nurse Administrators | 1 | 2017 | 45 | 0.140 |
Why?
|
| Biomedical Engineering | 1 | 2018 | 286 | 0.140 |
Why?
|
| Evidence-Based Medicine | 2 | 2006 | 3706 | 0.140 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 2 | 1 | 2017 | 50 | 0.140 |
Why?
|
| Oxygen Consumption | 2 | 2020 | 1880 | 0.140 |
Why?
|
| Neutrophils | 6 | 2017 | 3786 | 0.140 |
Why?
|
| Endosomes | 1 | 2019 | 522 | 0.140 |
Why?
|
| Neural Tube Defects | 1 | 2019 | 255 | 0.140 |
Why?
|
| Lysine | 2 | 2015 | 1000 | 0.140 |
Why?
|
| Vomiting | 2 | 2014 | 655 | 0.140 |
Why?
|
| Blood Transfusion | 1 | 2003 | 1309 | 0.140 |
Why?
|
| World Health Organization | 2 | 2006 | 1329 | 0.140 |
Why?
|
| Serum Amyloid A Protein | 1 | 2017 | 128 | 0.140 |
Why?
|
| Complement Activation | 1 | 2018 | 447 | 0.140 |
Why?
|
| Respiration | 2 | 2003 | 1665 | 0.140 |
Why?
|
| Chromium | 1 | 2017 | 133 | 0.140 |
Why?
|
| Anthropometry | 3 | 2018 | 1346 | 0.140 |
Why?
|
| Inheritance Patterns | 1 | 2019 | 344 | 0.130 |
Why?
|
| Accidents | 1 | 1997 | 164 | 0.130 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2017 | 205 | 0.130 |
Why?
|
| Candy | 1 | 2016 | 36 | 0.130 |
Why?
|
| Cytochrome P-450 Enzyme System | 5 | 2004 | 423 | 0.130 |
Why?
|
| Exoribonucleases | 1 | 2016 | 88 | 0.130 |
Why?
|
| Chromatography, High Pressure Liquid | 4 | 2008 | 1534 | 0.130 |
Why?
|
| Transcription Factor TFIIH | 1 | 2016 | 33 | 0.130 |
Why?
|
| Stress, Psychological | 5 | 2019 | 4530 | 0.130 |
Why?
|
| Aldehydes | 1 | 2017 | 170 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2015 | 2062 | 0.130 |
Why?
|
| Hair Removal | 1 | 2016 | 41 | 0.130 |
Why?
|
| Personnel Selection | 1 | 1998 | 201 | 0.130 |
Why?
|
| Methionine | 1 | 2019 | 573 | 0.130 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 3 | 2018 | 1560 | 0.130 |
Why?
|
| Animals | 35 | 2019 | 169246 | 0.130 |
Why?
|
| Cation Transport Proteins | 1 | 2019 | 326 | 0.130 |
Why?
|
| PubMed | 1 | 2016 | 129 | 0.130 |
Why?
|
| ras Proteins | 3 | 2011 | 1058 | 0.130 |
Why?
|
| Metabolome | 3 | 2019 | 1009 | 0.130 |
Why?
|
| Bronchial Provocation Tests | 5 | 2003 | 216 | 0.130 |
Why?
|
| Nitrogen Dioxide | 3 | 2005 | 534 | 0.130 |
Why?
|
| Probability | 3 | 2024 | 2479 | 0.130 |
Why?
|
| Radiography, Thoracic | 5 | 2023 | 1321 | 0.130 |
Why?
|
| ROC Curve | 2 | 2021 | 3628 | 0.130 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2019 | 540 | 0.130 |
Why?
|
| Endothelium, Vascular | 3 | 2018 | 4427 | 0.130 |
Why?
|
| Bronchial Neoplasms | 1 | 2016 | 110 | 0.130 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2015 | 9 | 0.130 |
Why?
|
| Sputum | 2 | 2014 | 517 | 0.130 |
Why?
|
| Reproductive History | 1 | 2017 | 210 | 0.130 |
Why?
|
| Formaldehyde | 1 | 2017 | 362 | 0.130 |
Why?
|
| Sequence Deletion | 3 | 2009 | 1497 | 0.130 |
Why?
|
| Copying Processes | 1 | 2015 | 4 | 0.130 |
Why?
|
| Mothers | 3 | 2019 | 2209 | 0.130 |
Why?
|
| Administration, Inhalation | 6 | 2023 | 1169 | 0.130 |
Why?
|
| Pectoralis Muscles | 1 | 2016 | 86 | 0.130 |
Why?
|
| Peptide Fragments | 1 | 2008 | 5151 | 0.130 |
Why?
|
| Brain Neoplasms | 3 | 2008 | 9118 | 0.130 |
Why?
|
| Accidental Falls | 2 | 2015 | 1080 | 0.130 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2015 | 5703 | 0.130 |
Why?
|
| Major Histocompatibility Complex | 1 | 2018 | 877 | 0.130 |
Why?
|
| Peptides | 2 | 2018 | 4354 | 0.130 |
Why?
|
| Gastrointestinal Neoplasms | 2 | 2013 | 957 | 0.130 |
Why?
|
| Health Education | 1 | 2002 | 1059 | 0.130 |
Why?
|
| Child Welfare | 1 | 2000 | 523 | 0.130 |
Why?
|
| Complement System Proteins | 1 | 2018 | 738 | 0.130 |
Why?
|
| Cytochrome P-450 CYP2E1 | 3 | 2014 | 41 | 0.130 |
Why?
|
| New York | 1 | 2018 | 882 | 0.120 |
Why?
|
| Head Protective Devices | 1 | 2016 | 118 | 0.120 |
Why?
|
| Search Engine | 1 | 2016 | 142 | 0.120 |
Why?
|
| Public Health | 7 | 2015 | 2679 | 0.120 |
Why?
|
| Overweight | 2 | 2020 | 2448 | 0.120 |
Why?
|
| Arsenates | 2 | 2006 | 10 | 0.120 |
Why?
|
| Menstruation | 1 | 2017 | 310 | 0.120 |
Why?
|
| Hypercholesterolemia | 1 | 2002 | 1145 | 0.120 |
Why?
|
| Compliance | 1 | 2015 | 100 | 0.120 |
Why?
|
| Knee Joint | 1 | 2004 | 1683 | 0.120 |
Why?
|
| Hemopexin | 1 | 2015 | 33 | 0.120 |
Why?
|
| Multifactorial Inheritance | 2 | 2021 | 1422 | 0.120 |
Why?
|
| Causality | 4 | 2011 | 1254 | 0.120 |
Why?
|
| Incidental Findings | 1 | 2020 | 698 | 0.120 |
Why?
|
| Body Composition | 1 | 2024 | 2462 | 0.120 |
Why?
|
| Genes, erbB-1 | 2 | 2007 | 163 | 0.120 |
Why?
|
| Lumbar Vertebrae | 1 | 2004 | 1885 | 0.120 |
Why?
|
| Child Nutrition Disorders | 1 | 2016 | 140 | 0.120 |
Why?
|
| Research Report | 1 | 2018 | 369 | 0.120 |
Why?
|
| Genetic Heterogeneity | 3 | 2020 | 736 | 0.120 |
Why?
|
| Respiration, Artificial | 4 | 2018 | 2726 | 0.120 |
Why?
|
| Receptors, Nicotinic | 1 | 2018 | 494 | 0.120 |
Why?
|
| United States Occupational Safety and Health Administration | 5 | 1999 | 54 | 0.120 |
Why?
|
| RNA | 1 | 2005 | 2720 | 0.120 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2021 | 1149 | 0.120 |
Why?
|
| Curcuma | 1 | 2014 | 12 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 454 | 0.120 |
Why?
|
| Sweat | 1 | 2015 | 57 | 0.120 |
Why?
|
| Soot | 2 | 2017 | 219 | 0.120 |
Why?
|
| Beverages | 1 | 2000 | 819 | 0.120 |
Why?
|
| Computer Simulation | 6 | 2018 | 6283 | 0.120 |
Why?
|
| Cilia | 1 | 2019 | 498 | 0.120 |
Why?
|
| Base Sequence | 10 | 2010 | 12421 | 0.120 |
Why?
|
| Umbilical Arteries | 1 | 2015 | 77 | 0.120 |
Why?
|
| RNA Stability | 1 | 2016 | 319 | 0.120 |
Why?
|
| Bronchoconstrictor Agents | 3 | 2003 | 77 | 0.120 |
Why?
|
| Educational Status | 5 | 2003 | 2515 | 0.120 |
Why?
|
| Nanoparticles | 2 | 2017 | 1985 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2017 | 693 | 0.110 |
Why?
|
| Nutrition Surveys | 2 | 2013 | 1738 | 0.110 |
Why?
|
| International Agencies | 1 | 2015 | 244 | 0.110 |
Why?
|
| Radiation Dosage | 2 | 2014 | 1967 | 0.110 |
Why?
|
| Protein Biosynthesis | 1 | 2021 | 2094 | 0.110 |
Why?
|
| Amoxicillin | 1 | 2015 | 182 | 0.110 |
Why?
|
| HLA-D Antigens | 1 | 2014 | 130 | 0.110 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily K | 1 | 2014 | 94 | 0.110 |
Why?
|
| Smad Proteins | 1 | 2014 | 157 | 0.110 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2015 | 168 | 0.110 |
Why?
|
| Intestinal Neoplasms | 1 | 2016 | 314 | 0.110 |
Why?
|
| Cytoskeleton | 1 | 2019 | 1179 | 0.110 |
Why?
|
| Micronutrients | 1 | 2017 | 390 | 0.110 |
Why?
|
| Lentivirus | 1 | 2016 | 518 | 0.110 |
Why?
|
| Tachycardia | 1 | 2016 | 599 | 0.110 |
Why?
|
| Academic Medical Centers | 3 | 2015 | 2784 | 0.110 |
Why?
|
| Leisure Activities | 1 | 2015 | 310 | 0.110 |
Why?
|
| Alu Elements | 1 | 2014 | 115 | 0.110 |
Why?
|
| Triglycerides | 2 | 2016 | 2464 | 0.110 |
Why?
|
| Colorectal Neoplasms | 4 | 2019 | 6974 | 0.110 |
Why?
|
| Nutrition Assessment | 1 | 2017 | 740 | 0.110 |
Why?
|
| Disability Evaluation | 2 | 2008 | 1835 | 0.110 |
Why?
|
| Energy-Generating Resources | 1 | 2012 | 5 | 0.110 |
Why?
|
| Lymphocytes | 8 | 2000 | 2614 | 0.110 |
Why?
|
| Cytokinesis | 1 | 2014 | 170 | 0.110 |
Why?
|
| Allergens | 2 | 1998 | 1443 | 0.110 |
Why?
|
| Loss of Heterozygosity | 4 | 2004 | 663 | 0.110 |
Why?
|
| Muscular Atrophy | 1 | 2016 | 335 | 0.110 |
Why?
|
| Cisplatin | 3 | 2012 | 1660 | 0.110 |
Why?
|
| Transglutaminases | 1 | 2014 | 200 | 0.110 |
Why?
|
| Antibodies, Bacterial | 1 | 2019 | 1479 | 0.110 |
Why?
|
| Micronucleus Tests | 4 | 2018 | 23 | 0.110 |
Why?
|
| Body Weights and Measures | 1 | 2013 | 208 | 0.110 |
Why?
|
| Ferritins | 1 | 2016 | 601 | 0.100 |
Why?
|
| Nucleic Acid Conformation | 1 | 2016 | 899 | 0.100 |
Why?
|
| Membrane Glycoproteins | 1 | 2004 | 3711 | 0.100 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2014 | 304 | 0.100 |
Why?
|
| Acid Ceramidase | 1 | 2012 | 21 | 0.100 |
Why?
|
| Gene Deletion | 2 | 1998 | 2675 | 0.100 |
Why?
|
| Family Characteristics | 2 | 2018 | 1003 | 0.100 |
Why?
|
| Respiratory Therapy | 1 | 1993 | 125 | 0.100 |
Why?
|
| Tear Gases | 1 | 1992 | 5 | 0.100 |
Why?
|
| Diabetes Mellitus | 6 | 2012 | 5889 | 0.100 |
Why?
|
| Polytetrafluoroethylene | 1 | 1994 | 245 | 0.100 |
Why?
|
| Follistatin | 1 | 2013 | 138 | 0.100 |
Why?
|
| Health Care Surveys | 3 | 2020 | 2434 | 0.100 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2013 | 113 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2024 | 3329 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 1 | 1994 | 268 | 0.100 |
Why?
|
| Tonsillar Neoplasms | 1 | 2013 | 50 | 0.100 |
Why?
|
| Energy Intake | 2 | 2017 | 2146 | 0.100 |
Why?
|
| Publications | 1 | 2015 | 195 | 0.100 |
Why?
|
| Vitamin E | 3 | 2022 | 874 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2016 | 567 | 0.100 |
Why?
|
| Enzyme Inhibitors | 1 | 2003 | 3728 | 0.100 |
Why?
|
| Cyprus | 4 | 2014 | 96 | 0.100 |
Why?
|
| Interleukin-2 Receptor beta Subunit | 1 | 2012 | 25 | 0.100 |
Why?
|
| Rest | 1 | 2017 | 948 | 0.100 |
Why?
|
| Myostatin | 1 | 2013 | 129 | 0.100 |
Why?
|
| Altitude | 1 | 2013 | 163 | 0.100 |
Why?
|
| Central Supply, Hospital | 1 | 1992 | 2 | 0.100 |
Why?
|
| Amino Acid Transport System A | 1 | 2012 | 5 | 0.100 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.100 |
Why?
|
| DNA, Bacterial | 1 | 2017 | 1478 | 0.100 |
Why?
|
| RNA Splicing | 1 | 2017 | 905 | 0.100 |
Why?
|
| Hematologic Tests | 3 | 2013 | 239 | 0.100 |
Why?
|
| Metabolism, Inborn Errors | 1 | 1994 | 292 | 0.100 |
Why?
|
| Glutarates | 1 | 2014 | 242 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 2 | 2009 | 9263 | 0.100 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2017 | 693 | 0.100 |
Why?
|
| DNA Glycosylases | 1 | 2013 | 125 | 0.100 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2013 | 260 | 0.100 |
Why?
|
| Porphobilinogen Synthase | 1 | 2011 | 29 | 0.100 |
Why?
|
| Activins | 1 | 2013 | 211 | 0.100 |
Why?
|
| Neuropsychological Tests | 5 | 2018 | 7140 | 0.100 |
Why?
|
| Penicillins | 1 | 2015 | 406 | 0.100 |
Why?
|
| Depression | 1 | 2012 | 8230 | 0.100 |
Why?
|
| Chlorides | 1 | 2015 | 666 | 0.100 |
Why?
|
| Cell Cycle Proteins | 3 | 2016 | 3445 | 0.100 |
Why?
|
| Construction Materials | 2 | 2021 | 60 | 0.100 |
Why?
|
| Blood Cell Count | 3 | 2005 | 406 | 0.100 |
Why?
|
| Gram-Negative Bacteria | 2 | 1993 | 275 | 0.100 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 1 | 1 | 2011 | 29 | 0.100 |
Why?
|
| Amidohydrolases | 1 | 2012 | 160 | 0.100 |
Why?
|
| Teaching | 1 | 2019 | 1171 | 0.100 |
Why?
|
| Malondialdehyde | 2 | 2002 | 113 | 0.100 |
Why?
|
| Rhinitis | 2 | 2000 | 753 | 0.100 |
Why?
|
| Biomass | 1 | 2012 | 135 | 0.090 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2011 | 22 | 0.090 |
Why?
|
| Family Health | 2 | 2017 | 1255 | 0.090 |
Why?
|
| Comorbidity | 5 | 2017 | 10590 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2012 | 259 | 0.090 |
Why?
|
| Open Reading Frames | 1 | 2015 | 818 | 0.090 |
Why?
|
| Gastrointestinal Diseases | 1 | 2020 | 1206 | 0.090 |
Why?
|
| Spectrometry, X-Ray Emission | 3 | 2021 | 144 | 0.090 |
Why?
|
| Dermatitis, Occupational | 1 | 1991 | 26 | 0.090 |
Why?
|
| Cell-Free System | 1 | 2012 | 339 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2024 | 4063 | 0.090 |
Why?
|
| Medicare | 2 | 2020 | 6809 | 0.090 |
Why?
|
| Developing Countries | 3 | 2000 | 2910 | 0.090 |
Why?
|
| Greece | 2 | 2004 | 340 | 0.090 |
Why?
|
| Breathing Exercises | 1 | 2011 | 59 | 0.090 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2013 | 428 | 0.090 |
Why?
|
| von Willebrand Factor | 2 | 2018 | 680 | 0.090 |
Why?
|
| Factor Analysis, Statistical | 2 | 2012 | 1001 | 0.090 |
Why?
|
| Absenteeism | 2 | 2004 | 247 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2017 | 924 | 0.090 |
Why?
|
| Selection Bias | 1 | 2012 | 360 | 0.090 |
Why?
|
| Disabled Persons | 1 | 2000 | 1210 | 0.090 |
Why?
|
| DNA Transposable Elements | 1 | 2014 | 764 | 0.090 |
Why?
|
| Asymptomatic Diseases | 1 | 2014 | 590 | 0.090 |
Why?
|
| Breast Neoplasms | 6 | 2019 | 21206 | 0.090 |
Why?
|
| Serpins | 1 | 2012 | 246 | 0.090 |
Why?
|
| Carpal Tunnel Syndrome | 1 | 1994 | 304 | 0.090 |
Why?
|
| Transferrin | 1 | 2011 | 283 | 0.090 |
Why?
|
| Abortion, Spontaneous | 3 | 2002 | 535 | 0.090 |
Why?
|
| Protein Kinases | 1 | 2017 | 1611 | 0.090 |
Why?
|
| Adiposity | 3 | 2021 | 1895 | 0.090 |
Why?
|
| Laparoscopy | 1 | 2022 | 2041 | 0.090 |
Why?
|
| Skin Tests | 2 | 2003 | 639 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2014 | 1524 | 0.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 4 | 2016 | 354 | 0.090 |
Why?
|
| Platinum Compounds | 1 | 2010 | 95 | 0.090 |
Why?
|
| Deglutition Disorders | 1 | 2016 | 640 | 0.090 |
Why?
|
| Immunoglobulin E | 5 | 2003 | 1506 | 0.090 |
Why?
|
| Mice | 17 | 2018 | 82029 | 0.090 |
Why?
|
| Emergency Medicine | 1 | 2019 | 1223 | 0.090 |
Why?
|
| Electronic Health Records | 3 | 2023 | 4887 | 0.090 |
Why?
|
| Sperm Motility | 5 | 2003 | 265 | 0.090 |
Why?
|
| Pulmonary Embolism | 1 | 2023 | 2599 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2011 | 246 | 0.090 |
Why?
|
| Genome | 2 | 2017 | 1754 | 0.090 |
Why?
|
| Leukocyte Count | 5 | 2005 | 1609 | 0.090 |
Why?
|
| Prostatic Neoplasms | 3 | 2019 | 11101 | 0.080 |
Why?
|
| Heterozygote | 4 | 2009 | 2798 | 0.080 |
Why?
|
| Caspase 9 | 1 | 2010 | 184 | 0.080 |
Why?
|
| Kidney Diseases | 1 | 2001 | 2100 | 0.080 |
Why?
|
| Cell Line, Tumor | 7 | 2019 | 17140 | 0.080 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2011 | 257 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 2011 | 418 | 0.080 |
Why?
|
| Aging | 3 | 2022 | 8744 | 0.080 |
Why?
|
| Statistics as Topic | 3 | 2003 | 2357 | 0.080 |
Why?
|
| Republic of Korea | 1 | 2012 | 591 | 0.080 |
Why?
|
| Iron | 2 | 2016 | 1813 | 0.080 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 2006 | 2486 | 0.080 |
Why?
|
| Military Personnel | 1 | 2019 | 1261 | 0.080 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 2040 | 0.080 |
Why?
|
| Individuality | 1 | 2011 | 307 | 0.080 |
Why?
|
| Laser Therapy | 1 | 2016 | 1107 | 0.080 |
Why?
|
| Health Status | 2 | 2021 | 4091 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 2 | 2017 | 3620 | 0.080 |
Why?
|
| Inflammation Mediators | 1 | 1998 | 1892 | 0.080 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2011 | 1062 | 0.080 |
Why?
|
| Pancreatic Neoplasms | 3 | 2016 | 5446 | 0.080 |
Why?
|
| Carcinoma, Large Cell | 2 | 2008 | 114 | 0.080 |
Why?
|
| Inservice Training | 1 | 1992 | 375 | 0.080 |
Why?
|
| Medical Staff, Hospital | 1 | 1993 | 603 | 0.080 |
Why?
|
| Respiratory Hypersensitivity | 2 | 2003 | 272 | 0.080 |
Why?
|
| Secretory Leukocyte Peptidase Inhibitor | 1 | 2009 | 23 | 0.080 |
Why?
|
| BRCA2 Protein | 1 | 2014 | 802 | 0.080 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2017 | 1247 | 0.080 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2013 | 614 | 0.080 |
Why?
|
| Cocaine | 1 | 1994 | 947 | 0.080 |
Why?
|
| Oxidoreductases | 1 | 2011 | 410 | 0.080 |
Why?
|
| Semen | 2 | 2003 | 349 | 0.080 |
Why?
|
| Disinfectants | 1 | 2010 | 129 | 0.080 |
Why?
|
| Metabolic Detoxication, Phase II | 1 | 2008 | 5 | 0.080 |
Why?
|
| Metabolic Detoxication, Phase I | 1 | 2008 | 4 | 0.080 |
Why?
|
| Myocardial Infarction | 1 | 2010 | 11519 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 1 | 1 | 2011 | 640 | 0.080 |
Why?
|
| Organ Specificity | 1 | 2014 | 1968 | 0.080 |
Why?
|
| Liver Diseases | 1 | 1997 | 1305 | 0.080 |
Why?
|
| Life Style | 3 | 2021 | 3932 | 0.080 |
Why?
|
| Immunohistochemistry | 5 | 2016 | 11095 | 0.080 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2014 | 11878 | 0.080 |
Why?
|
| Primary Health Care | 1 | 2005 | 4746 | 0.080 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2011 | 1151 | 0.080 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2009 | 2433 | 0.080 |
Why?
|
| Lung Transplantation | 1 | 2018 | 1309 | 0.080 |
Why?
|
| Pain | 1 | 2004 | 5100 | 0.080 |
Why?
|
| Testicular Neoplasms | 1 | 1995 | 806 | 0.080 |
Why?
|
| Fresh Water | 1 | 2008 | 83 | 0.080 |
Why?
|
| Germ-Line Mutation | 2 | 2023 | 1885 | 0.080 |
Why?
|
| Exercise Test | 3 | 2022 | 2186 | 0.080 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 2016 | 1489 | 0.080 |
Why?
|
| Glucuronosyltransferase | 1 | 2009 | 136 | 0.080 |
Why?
|
| Berylliosis | 1 | 2008 | 9 | 0.080 |
Why?
|
| Intestines | 1 | 2017 | 1909 | 0.080 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 1 | 2008 | 34 | 0.080 |
Why?
|
| Hydroxyprostaglandin Dehydrogenases | 1 | 2008 | 31 | 0.080 |
Why?
|
| Blood Proteins | 2 | 2008 | 1191 | 0.080 |
Why?
|
| Refugees | 1 | 2016 | 615 | 0.080 |
Why?
|
| Tumor Microenvironment | 2 | 2018 | 3948 | 0.080 |
Why?
|
| Cholangiocarcinoma | 1 | 2014 | 561 | 0.080 |
Why?
|
| Communicable Diseases | 1 | 2016 | 874 | 0.080 |
Why?
|
| Mental Health | 1 | 2022 | 3275 | 0.080 |
Why?
|
| Emphysema | 1 | 2011 | 236 | 0.080 |
Why?
|
| Education, Medical, Graduate | 3 | 2019 | 2420 | 0.080 |
Why?
|
| Bile Duct Neoplasms | 1 | 2014 | 614 | 0.080 |
Why?
|
| Observation | 1 | 2010 | 310 | 0.080 |
Why?
|
| Phthalic Acids | 2 | 2003 | 487 | 0.070 |
Why?
|
| Gelsolin | 1 | 2008 | 189 | 0.070 |
Why?
|
| Research Design | 6 | 2024 | 6211 | 0.070 |
Why?
|
| Serum | 1 | 2009 | 206 | 0.070 |
Why?
|
| Sunlight | 1 | 2010 | 337 | 0.070 |
Why?
|
| Receptors, IgG | 1 | 2011 | 564 | 0.070 |
Why?
|
| Benzo(a)pyrene | 3 | 2002 | 28 | 0.070 |
Why?
|
| Neoplasm Metastasis | 2 | 2017 | 4912 | 0.070 |
Why?
|
| Interleukins | 1 | 2013 | 796 | 0.070 |
Why?
|
| Pulsatile Flow | 1 | 2009 | 320 | 0.070 |
Why?
|
| Referral and Consultation | 2 | 2012 | 3620 | 0.070 |
Why?
|
| Tandem Repeat Sequences | 1 | 2008 | 183 | 0.070 |
Why?
|
| Emergency Service, Hospital | 2 | 2020 | 7951 | 0.070 |
Why?
|
| Organizational Policy | 2 | 2017 | 435 | 0.070 |
Why?
|
| Abdominal Pain | 1 | 2014 | 1070 | 0.070 |
Why?
|
| Patient Admission | 2 | 2019 | 1365 | 0.070 |
Why?
|
| Isocitrate Dehydrogenase | 1 | 2014 | 951 | 0.070 |
Why?
|
| Housing | 3 | 2018 | 683 | 0.070 |
Why?
|
| Registries | 3 | 2013 | 8375 | 0.070 |
Why?
|
| Insurance, Health | 1 | 2020 | 2517 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2009 | 452 | 0.070 |
Why?
|
| Menstrual Cycle | 2 | 2001 | 546 | 0.070 |
Why?
|
| Nurses | 1 | 2017 | 2501 | 0.070 |
Why?
|
| Pulmonary Ventilation | 2 | 2001 | 375 | 0.070 |
Why?
|
| Liver Failure, Acute | 1 | 2009 | 182 | 0.070 |
Why?
|
| RNA-Binding Proteins | 2 | 2022 | 1890 | 0.070 |
Why?
|
| beta Catenin | 1 | 2012 | 1047 | 0.070 |
Why?
|
| Chest Pain | 1 | 1994 | 1101 | 0.070 |
Why?
|
| Food Analysis | 1 | 2007 | 103 | 0.070 |
Why?
|
| Biopsy, Needle | 2 | 2016 | 1622 | 0.070 |
Why?
|
| Asparagine | 1 | 2007 | 120 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
| Albuminuria | 1 | 1991 | 658 | 0.070 |
Why?
|
| Health Expenditures | 1 | 2020 | 2389 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2009 | 458 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2016 | 3402 | 0.070 |
Why?
|
| Interleukin-2 | 1 | 2014 | 1895 | 0.070 |
Why?
|
| Nicotinamide Phosphoribosyltransferase | 1 | 2007 | 85 | 0.070 |
Why?
|
| Alphapapillomavirus | 1 | 2009 | 219 | 0.070 |
Why?
|
| Inflammasomes | 1 | 2012 | 540 | 0.070 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2012 | 2521 | 0.070 |
Why?
|
| Rare Diseases | 1 | 2012 | 631 | 0.070 |
Why?
|
| Tea | 1 | 2008 | 290 | 0.070 |
Why?
|
| Disease Models, Animal | 7 | 2015 | 18349 | 0.070 |
Why?
|
| Histones | 1 | 2017 | 2601 | 0.070 |
Why?
|
| Parathion | 3 | 2000 | 14 | 0.070 |
Why?
|
| Enzymes | 1 | 2008 | 254 | 0.070 |
Why?
|
| Specimen Handling | 2 | 2010 | 708 | 0.070 |
Why?
|
| Transfection | 1 | 2014 | 5755 | 0.070 |
Why?
|
| Organothiophosphorus Compounds | 3 | 2000 | 14 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2015 | 5341 | 0.070 |
Why?
|
| Spectrophotometry, Atomic | 3 | 2014 | 80 | 0.070 |
Why?
|
| 3' Untranslated Regions | 1 | 2008 | 515 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 3671 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2009 | 661 | 0.070 |
Why?
|
| Alcoholic Beverages | 2 | 2018 | 266 | 0.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2007 | 267 | 0.070 |
Why?
|
| DNA Mutational Analysis | 3 | 2015 | 4120 | 0.060 |
Why?
|
| Health Personnel | 2 | 2016 | 3385 | 0.060 |
Why?
|
| Thrombocytopenia | 1 | 2014 | 1179 | 0.060 |
Why?
|
| Calcifediol | 1 | 2007 | 160 | 0.060 |
Why?
|
| Toes | 1 | 2007 | 209 | 0.060 |
Why?
|
| Threshold Limit Values | 1 | 2005 | 12 | 0.060 |
Why?
|
| Body Height | 2 | 2010 | 1565 | 0.060 |
Why?
|
| Mice, Transgenic | 4 | 2017 | 9561 | 0.060 |
Why?
|
| Sports | 1 | 2012 | 703 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3433 | 0.060 |
Why?
|
| Viral Load | 2 | 2018 | 3396 | 0.060 |
Why?
|
| Fabaceae | 1 | 2006 | 103 | 0.060 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 461 | 0.060 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2009 | 1134 | 0.060 |
Why?
|
| Binding Sites | 1 | 2014 | 6020 | 0.060 |
Why?
|
| Oncogenes | 1 | 2011 | 1234 | 0.060 |
Why?
|
| Aryldialkylphosphatase | 2 | 2003 | 64 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2018 | 4413 | 0.060 |
Why?
|
| Respiratory Protective Devices | 1 | 2005 | 47 | 0.060 |
Why?
|
| Blood Chemical Analysis | 1 | 2007 | 435 | 0.060 |
Why?
|
| Quality of Life | 4 | 2022 | 13490 | 0.060 |
Why?
|
| Genes, p16 | 2 | 2007 | 159 | 0.060 |
Why?
|
| Needs Assessment | 2 | 2019 | 1141 | 0.060 |
Why?
|
| Cholesterol | 3 | 2010 | 2914 | 0.060 |
Why?
|
| Mitochondrial Proteins | 1 | 2011 | 979 | 0.060 |
Why?
|
| Adaptor Proteins, Signal Transducing | 2 | 2015 | 2909 | 0.060 |
Why?
|
| Infant, Premature | 1 | 2015 | 2124 | 0.060 |
Why?
|
| Maximum Allowable Concentration | 3 | 2005 | 64 | 0.060 |
Why?
|
| Histocompatibility Antigens Class I | 1 | 2011 | 1361 | 0.060 |
Why?
|
| Proline | 2 | 2009 | 455 | 0.060 |
Why?
|
| Muscle Fatigue | 1 | 2005 | 96 | 0.060 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2014 | 10760 | 0.060 |
Why?
|
| National Health Programs | 2 | 2010 | 442 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2009 | 2227 | 0.060 |
Why?
|
| Tobacco, Smokeless | 1 | 2006 | 133 | 0.060 |
Why?
|
| Endothelial Cells | 3 | 2021 | 3589 | 0.060 |
Why?
|
| Aspartic Acid | 1 | 2007 | 577 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 6 | 2 | 2016 | 370 | 0.060 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 633 | 0.060 |
Why?
|
| Oligomenorrhea | 2 | 2001 | 42 | 0.060 |
Why?
|
| Chemical Warfare | 1 | 2004 | 18 | 0.060 |
Why?
|
| Toxicogenetics | 1 | 2004 | 19 | 0.060 |
Why?
|
| Cadherins | 1 | 2009 | 905 | 0.060 |
Why?
|
| Wood | 2 | 1995 | 94 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2017 | 2171 | 0.060 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 2 | 2001 | 977 | 0.060 |
Why?
|
| Rats, Inbred WKY | 4 | 2008 | 150 | 0.060 |
Why?
|
| Introns | 1 | 2007 | 966 | 0.060 |
Why?
|
| Hematocrit | 1 | 2005 | 623 | 0.060 |
Why?
|
| Macrophages | 2 | 2017 | 5799 | 0.060 |
Why?
|
| Fibrinogen | 2 | 2005 | 891 | 0.060 |
Why?
|
| Heart Ventricles | 1 | 2016 | 3841 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2009 | 4580 | 0.060 |
Why?
|
| Health Planning | 2 | 2020 | 233 | 0.060 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2018 | 10399 | 0.060 |
Why?
|
| Limit of Detection | 2 | 2018 | 277 | 0.060 |
Why?
|
| Cathepsin H | 1 | 2023 | 10 | 0.060 |
Why?
|
| Transition Elements | 1 | 2003 | 15 | 0.060 |
Why?
|
| Thrombosis | 1 | 2018 | 2957 | 0.060 |
Why?
|
| Sheep | 1 | 2006 | 1451 | 0.060 |
Why?
|
| Hydrocarbons | 2 | 2013 | 105 | 0.060 |
Why?
|
| International Cooperation | 3 | 2016 | 1436 | 0.050 |
Why?
|
| Models, Animal | 3 | 2018 | 2120 | 0.050 |
Why?
|
| Temperature | 2 | 2002 | 2234 | 0.050 |
Why?
|
| Asphyxia | 1 | 2004 | 60 | 0.050 |
Why?
|
| Ethics, Professional | 1 | 2004 | 100 | 0.050 |
Why?
|
| Liability, Legal | 1 | 2005 | 209 | 0.050 |
Why?
|
| Skin | 1 | 2017 | 4503 | 0.050 |
Why?
|
| Burns | 1 | 2015 | 1899 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 1903 | 0.050 |
Why?
|
| Cardiovascular System | 1 | 2010 | 841 | 0.050 |
Why?
|
| Necrosis | 1 | 2007 | 1616 | 0.050 |
Why?
|
| RNA Interference | 1 | 2012 | 2832 | 0.050 |
Why?
|
| Surface-Active Agents | 1 | 2023 | 151 | 0.050 |
Why?
|
| Nebulizers and Vaporizers | 1 | 2023 | 139 | 0.050 |
Why?
|
| Task Performance and Analysis | 1 | 2007 | 771 | 0.050 |
Why?
|
| Physical Therapy Modalities | 2 | 1999 | 533 | 0.050 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2011 | 1613 | 0.050 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 2001 | 492 | 0.050 |
Why?
|
| No-Observed-Adverse-Effect Level | 1 | 2002 | 25 | 0.050 |
Why?
|
| Blood Glucose | 2 | 2010 | 6430 | 0.050 |
Why?
|
| Genetic Code | 1 | 2003 | 139 | 0.050 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2019 | 9419 | 0.050 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2005 | 249 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2004 | 615 | 0.050 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2014 | 4415 | 0.050 |
Why?
|
| Obesity, Morbid | 1 | 2013 | 1298 | 0.050 |
Why?
|
| Feeding Behavior | 1 | 2015 | 3205 | 0.050 |
Why?
|
| Leptin | 1 | 2010 | 1599 | 0.050 |
Why?
|
| DNA-Formamidopyrimidine Glycosylase | 1 | 2002 | 18 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2011 | 1715 | 0.050 |
Why?
|
| Nasopharyngeal Neoplasms | 2 | 2009 | 290 | 0.050 |
Why?
|
| Atmospheric Pressure | 1 | 2002 | 48 | 0.050 |
Why?
|
| Safety | 3 | 2014 | 1159 | 0.050 |
Why?
|
| Exanthema | 1 | 2007 | 503 | 0.050 |
Why?
|
| Body Weight | 3 | 2009 | 4627 | 0.050 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2004 | 241 | 0.050 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2003 | 379 | 0.050 |
Why?
|
| Self Disclosure | 1 | 2003 | 248 | 0.050 |
Why?
|
| Traction | 1 | 2022 | 112 | 0.050 |
Why?
|
| Liver Neoplasms | 2 | 2014 | 4362 | 0.050 |
Why?
|
| Protein Binding | 1 | 2014 | 9343 | 0.050 |
Why?
|
| Dyspnea | 1 | 2010 | 1352 | 0.050 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5520 | 0.050 |
Why?
|
| Exercise Therapy | 1 | 2009 | 939 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2011 | 2457 | 0.050 |
Why?
|
| Flavonoids | 1 | 2005 | 447 | 0.050 |
Why?
|
| Hospitals, Special | 1 | 2002 | 90 | 0.050 |
Why?
|
| Ubiquitination | 2 | 2018 | 1009 | 0.050 |
Why?
|
| Cocarcinogenesis | 2 | 1999 | 49 | 0.050 |
Why?
|
| Recurrence | 3 | 2013 | 8509 | 0.050 |
Why?
|
| Government Agencies | 1 | 2002 | 161 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 2 | 2018 | 2596 | 0.050 |
Why?
|
| Drug Therapy | 1 | 2005 | 504 | 0.050 |
Why?
|
| Software | 2 | 2014 | 4478 | 0.050 |
Why?
|
| Ultraviolet Rays | 1 | 2007 | 1103 | 0.050 |
Why?
|
| Medical History Taking | 2 | 2021 | 779 | 0.050 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2011 | 2271 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 1999 | 594 | 0.050 |
Why?
|
| Decontamination | 1 | 2001 | 73 | 0.050 |
Why?
|
| Ions | 1 | 2022 | 255 | 0.050 |
Why?
|
| Editorial Policies | 1 | 2006 | 458 | 0.050 |
Why?
|
| England | 1 | 2023 | 533 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 4648 | 0.050 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2011 | 2885 | 0.050 |
Why?
|
| Pyruvaldehyde | 1 | 2021 | 16 | 0.050 |
Why?
|
| Lymphocyte Activation | 4 | 2001 | 5505 | 0.050 |
Why?
|
| Phosphates | 1 | 2005 | 765 | 0.050 |
Why?
|
| Least-Squares Analysis | 2 | 1999 | 367 | 0.050 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 985 | 0.050 |
Why?
|
| Propylene Glycol | 1 | 2021 | 30 | 0.050 |
Why?
|
| Systole | 1 | 2003 | 937 | 0.050 |
Why?
|
| Actins | 1 | 2008 | 2064 | 0.050 |
Why?
|
| Multifactor Dimensionality Reduction | 1 | 2020 | 10 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2005 | 2474 | 0.050 |
Why?
|
| Vanadates | 1 | 2000 | 82 | 0.050 |
Why?
|
| Waist-Hip Ratio | 2 | 2014 | 520 | 0.050 |
Why?
|
| Multicenter Studies as Topic | 2 | 2018 | 1737 | 0.050 |
Why?
|
| Agrochemicals | 1 | 2000 | 9 | 0.050 |
Why?
|
| Diastole | 1 | 2003 | 785 | 0.050 |
Why?
|
| Transplantation Chimera | 1 | 2003 | 594 | 0.050 |
Why?
|
| Nutritional Sciences | 1 | 2002 | 148 | 0.050 |
Why?
|
| Metallothionein | 1 | 2000 | 62 | 0.050 |
Why?
|
| Atrazine | 1 | 2000 | 9 | 0.050 |
Why?
|
| Humidity | 1 | 2002 | 207 | 0.050 |
Why?
|
| Solubility | 1 | 2002 | 1083 | 0.050 |
Why?
|
| Epoxy Compounds | 2 | 1991 | 137 | 0.040 |
Why?
|
| Dendritic Cells | 1 | 2012 | 2747 | 0.040 |
Why?
|
| Acetates | 1 | 2022 | 317 | 0.040 |
Why?
|
| Human Genome Project | 1 | 2001 | 202 | 0.040 |
Why?
|
| 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 1 | 2000 | 4 | 0.040 |
Why?
|
| Hearing Tests | 1 | 2001 | 123 | 0.040 |
Why?
|
| Calibration | 1 | 2023 | 819 | 0.040 |
Why?
|
| Neurons | 1 | 2020 | 9514 | 0.040 |
Why?
|
| Antioxidants | 3 | 1998 | 1673 | 0.040 |
Why?
|
| Immunoglobulin M | 1 | 2005 | 1528 | 0.040 |
Why?
|
| Receptors, Interleukin-2 | 2 | 2001 | 564 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 7608 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2010 | 2846 | 0.040 |
Why?
|
| Singapore | 1 | 2021 | 300 | 0.040 |
Why?
|
| X-Rays | 1 | 2021 | 311 | 0.040 |
Why?
|
| Mice, Nude | 1 | 2006 | 3623 | 0.040 |
Why?
|
| Diarrhea | 1 | 2007 | 1320 | 0.040 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2004 | 588 | 0.040 |
Why?
|
| Iceland | 1 | 2020 | 183 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2009 | 1886 | 0.040 |
Why?
|
| Thorax | 1 | 2023 | 557 | 0.040 |
Why?
|
| Bronchodilator Agents | 1 | 2023 | 518 | 0.040 |
Why?
|
| Infertility, Male | 1 | 2003 | 397 | 0.040 |
Why?
|
| Oxidants, Photochemical | 1 | 2000 | 77 | 0.040 |
Why?
|
| Chorionic Gonadotropin | 1 | 2002 | 458 | 0.040 |
Why?
|
| Aspirin | 1 | 2011 | 3135 | 0.040 |
Why?
|
| Sulfuric Acids | 1 | 1999 | 36 | 0.040 |
Why?
|
| Physical Exertion | 1 | 2002 | 668 | 0.040 |
Why?
|
| Stroke | 1 | 2002 | 9755 | 0.040 |
Why?
|
| Nose Diseases | 1 | 2000 | 78 | 0.040 |
Why?
|
| Luteinizing Hormone | 2 | 1999 | 822 | 0.040 |
Why?
|
| Nitric Acid | 1 | 1999 | 10 | 0.040 |
Why?
|
| Molecular Sequence Data | 7 | 2004 | 17622 | 0.040 |
Why?
|
| Menstruation Disturbances | 1 | 2000 | 143 | 0.040 |
Why?
|
| Octoxynol | 1 | 1999 | 76 | 0.040 |
Why?
|
| Tetanus | 1 | 2019 | 52 | 0.040 |
Why?
|
| Diphtheria | 1 | 2019 | 32 | 0.040 |
Why?
|
| Diagnosis, Differential | 3 | 2014 | 13014 | 0.040 |
Why?
|
| Insurance, Disability | 1 | 1999 | 26 | 0.040 |
Why?
|
| Peak Expiratory Flow Rate | 2 | 1996 | 144 | 0.040 |
Why?
|
| Periodicity | 1 | 2000 | 348 | 0.040 |
Why?
|
| Deoxyribonuclease HpaII | 1 | 1998 | 16 | 0.040 |
Why?
|
| Organometallic Compounds | 1 | 2002 | 648 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3447 | 0.040 |
Why?
|
| Ultrasonography | 1 | 2012 | 6004 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2003 | 609 | 0.040 |
Why?
|
| Artificial Intelligence | 2 | 2024 | 2665 | 0.040 |
Why?
|
| Up-Regulation | 3 | 2016 | 4146 | 0.040 |
Why?
|
| Eosinophil Granule Proteins | 1 | 1998 | 29 | 0.040 |
Why?
|
| Cataract | 1 | 2005 | 837 | 0.040 |
Why?
|
| Fluorescence | 1 | 2021 | 756 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5367 | 0.040 |
Why?
|
| Cell Culture Techniques | 2 | 2003 | 1667 | 0.040 |
Why?
|
| Uranium | 1 | 2018 | 24 | 0.040 |
Why?
|
| Sonication | 1 | 1999 | 79 | 0.040 |
Why?
|
| Hyperlipidemias | 1 | 2003 | 772 | 0.040 |
Why?
|
| Washington | 1 | 2019 | 315 | 0.040 |
Why?
|
| Acid Anhydride Hydrolases | 1 | 1998 | 67 | 0.040 |
Why?
|
| Muscle, Skeletal | 1 | 2013 | 4978 | 0.040 |
Why?
|
| Exons | 3 | 1999 | 2394 | 0.040 |
Why?
|
| Down-Regulation | 2 | 2019 | 2937 | 0.040 |
Why?
|
| Pharyngitis | 1 | 2000 | 222 | 0.040 |
Why?
|
| Autoradiography | 1 | 1999 | 727 | 0.040 |
Why?
|
| Forecasting | 2 | 2016 | 2945 | 0.040 |
Why?
|
| Inspiratory Capacity | 1 | 1997 | 35 | 0.040 |
Why?
|
| Discriminant Analysis | 2 | 2009 | 222 | 0.040 |
Why?
|
| Guinea Pigs | 1 | 1999 | 1310 | 0.040 |
Why?
|
| Disaster Planning | 1 | 2004 | 560 | 0.040 |
Why?
|
| Pregnancy Trimesters | 1 | 2019 | 197 | 0.040 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2019 | 169 | 0.040 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 2001 | 1441 | 0.040 |
Why?
|
| Ships | 1 | 1997 | 53 | 0.040 |
Why?
|
| Substance-Related Disorders | 1 | 1994 | 4423 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2008 | 2631 | 0.040 |
Why?
|
| Carotid Arteries | 1 | 2022 | 942 | 0.040 |
Why?
|
| Angiopoietins | 1 | 2017 | 86 | 0.040 |
Why?
|
| Curriculum | 2 | 2022 | 3782 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2008 | 2650 | 0.040 |
Why?
|
| Receptors, IgE | 1 | 1999 | 375 | 0.040 |
Why?
|
| Equipment Design | 1 | 2005 | 3522 | 0.030 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2021 | 801 | 0.030 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2012 | 3251 | 0.030 |
Why?
|
| HEK293 Cells | 2 | 2020 | 4283 | 0.030 |
Why?
|
| Immunologic Memory | 2 | 2001 | 1377 | 0.030 |
Why?
|
| Medical Subject Headings | 1 | 2016 | 16 | 0.030 |
Why?
|
| Pandemics | 3 | 2023 | 8748 | 0.030 |
Why?
|
| beta Carotene | 1 | 1998 | 523 | 0.030 |
Why?
|
| Lymphangiogenesis | 1 | 2018 | 171 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2018 | 283 | 0.030 |
Why?
|
| Colectomy | 1 | 2022 | 696 | 0.030 |
Why?
|
| Emergency Medical Technicians | 1 | 1997 | 119 | 0.030 |
Why?
|
| Radiography | 3 | 1999 | 6983 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2018 | 325 | 0.030 |
Why?
|
| Vinyl Compounds | 1 | 1976 | 21 | 0.030 |
Why?
|
| Anticarcinogenic Agents | 1 | 1998 | 251 | 0.030 |
Why?
|
| Developed Countries | 1 | 2000 | 451 | 0.030 |
Why?
|
| Syria | 1 | 2016 | 86 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2015 | 7477 | 0.030 |
Why?
|
| Indiana | 1 | 2016 | 93 | 0.030 |
Why?
|
| Data Collection | 2 | 2014 | 3327 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2001 | 1864 | 0.030 |
Why?
|
| Personnel, Hospital | 2 | 1996 | 285 | 0.030 |
Why?
|
| Follicle Stimulating Hormone | 1 | 1998 | 727 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 2011 | 4262 | 0.030 |
Why?
|
| Chemokines | 1 | 2000 | 963 | 0.030 |
Why?
|
| Running | 1 | 2021 | 490 | 0.030 |
Why?
|
| Length of Stay | 1 | 2010 | 6498 | 0.030 |
Why?
|
| Audiometry | 1 | 1997 | 253 | 0.030 |
Why?
|
| Diet Surveys | 1 | 2000 | 1160 | 0.030 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2017 | 252 | 0.030 |
Why?
|
| Histone Code | 1 | 2017 | 160 | 0.030 |
Why?
|
| Language Development | 1 | 2017 | 183 | 0.030 |
Why?
|
| Oximetry | 1 | 1999 | 462 | 0.030 |
Why?
|
| Lebanon | 1 | 2016 | 245 | 0.030 |
Why?
|
| Hypoxanthine Phosphoribosyltransferase | 1 | 1995 | 69 | 0.030 |
Why?
|
| Repressor Proteins | 1 | 2007 | 2982 | 0.030 |
Why?
|
| Ethics, Medical | 1 | 2001 | 785 | 0.030 |
Why?
|
| Schools | 2 | 1997 | 1498 | 0.030 |
Why?
|
| Glycine | 1 | 2019 | 672 | 0.030 |
Why?
|
| Chromosome Deletion | 2 | 2005 | 1385 | 0.030 |
Why?
|
| Social Change | 2 | 1988 | 152 | 0.030 |
Why?
|
| Insulin | 2 | 2023 | 6607 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2003 | 5027 | 0.030 |
Why?
|
| Lead Poisoning | 1 | 2018 | 323 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2016 | 138 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1999 | 573 | 0.030 |
Why?
|
| Immunophilins | 1 | 2015 | 20 | 0.030 |
Why?
|
| Physicians | 1 | 1993 | 4598 | 0.030 |
Why?
|
| Health Services | 1 | 2000 | 755 | 0.030 |
Why?
|
| Spain | 1 | 1997 | 485 | 0.030 |
Why?
|
| Engineering | 1 | 1995 | 56 | 0.030 |
Why?
|
| Carotenoids | 1 | 1998 | 620 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 2018 | 557 | 0.030 |
Why?
|
| Immunoglobulin G | 2 | 2005 | 4568 | 0.030 |
Why?
|
| Guideline Adherence | 1 | 2005 | 2235 | 0.030 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 3 | 2001 | 325 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2018 | 752 | 0.030 |
Why?
|
| Paper | 1 | 2015 | 83 | 0.030 |
Why?
|
| Airway Resistance | 2 | 2012 | 407 | 0.030 |
Why?
|
| Feasibility Studies | 3 | 2009 | 5315 | 0.030 |
Why?
|
| Acetylation | 1 | 1998 | 1056 | 0.030 |
Why?
|
| Cardiomyopathies | 1 | 2007 | 2056 | 0.030 |
Why?
|
| Ascorbic Acid | 1 | 1998 | 658 | 0.030 |
Why?
|
| Myocarditis | 1 | 2003 | 802 | 0.030 |
Why?
|
| Periodicals as Topic | 1 | 2006 | 1465 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 20 | 1 | 2015 | 127 | 0.030 |
Why?
|
| Reproduction | 1 | 1999 | 646 | 0.030 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2001 | 1815 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2023 | 1946 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2017 | 631 | 0.030 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 610 | 0.030 |
Why?
|
| Drug Resistance, Microbial | 1 | 2017 | 830 | 0.030 |
Why?
|
| Forced Expiratory Flow Rates | 1 | 1994 | 75 | 0.030 |
Why?
|
| Osteopontin | 1 | 2016 | 306 | 0.030 |
Why?
|
| Somatostatin | 1 | 2016 | 458 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2017 | 527 | 0.030 |
Why?
|
| Medical Records | 1 | 2000 | 1410 | 0.030 |
Why?
|
| Bronchospirometry | 1 | 1994 | 10 | 0.030 |
Why?
|
| Nitric Oxide Synthase | 1 | 1997 | 911 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 1999 | 1836 | 0.030 |
Why?
|
| Behavioral Risk Factor Surveillance System | 1 | 2015 | 211 | 0.030 |
Why?
|
| Normal Distribution | 1 | 2014 | 272 | 0.030 |
Why?
|
| Menarche | 1 | 2017 | 538 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p15 | 1 | 2014 | 76 | 0.030 |
Why?
|
| Monocytes | 2 | 2002 | 2605 | 0.030 |
Why?
|
| Spectrophotometry | 1 | 1994 | 292 | 0.030 |
Why?
|
| Electric Conductivity | 1 | 2015 | 407 | 0.030 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2015 | 199 | 0.030 |
Why?
|
| Legislation as Topic | 1 | 2014 | 76 | 0.030 |
Why?
|
| Rats | 7 | 2008 | 23760 | 0.030 |
Why?
|
| Ceramics | 1 | 2014 | 113 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 1995 | 297 | 0.030 |
Why?
|
| Antihypertensive Agents | 1 | 2003 | 2029 | 0.030 |
Why?
|
| Risk Reduction Behavior | 1 | 2020 | 1119 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 858 | 0.030 |
Why?
|
| Computer Systems | 1 | 2015 | 469 | 0.030 |
Why?
|
| Poverty | 1 | 2005 | 2720 | 0.030 |
Why?
|
| Cost of Illness | 1 | 2003 | 1951 | 0.030 |
Why?
|
| Hemodynamics | 2 | 2014 | 4194 | 0.030 |
Why?
|
| Fetus | 1 | 2001 | 1883 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2002 | 2025 | 0.030 |
Why?
|
| Chromogranin A | 1 | 2013 | 47 | 0.030 |
Why?
|
| Alkylation | 1 | 2013 | 84 | 0.030 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2010 | 3231 | 0.030 |
Why?
|
| Cell Differentiation | 2 | 2009 | 11669 | 0.030 |
Why?
|
| North America | 1 | 2017 | 1289 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2015 | 293 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2018 | 812 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 1511 | 0.030 |
Why?
|
| Central America | 1 | 1993 | 69 | 0.030 |
Why?
|
| Naphthalenes | 1 | 2014 | 198 | 0.030 |
Why?
|
| Biostatistics | 1 | 2014 | 163 | 0.030 |
Why?
|
| HLA Antigens | 1 | 2018 | 1334 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2016 | 303 | 0.030 |
Why?
|
| Career Choice | 1 | 2019 | 769 | 0.030 |
Why?
|
| Cells, Cultured | 6 | 2019 | 19015 | 0.030 |
Why?
|
| Texas | 1 | 2014 | 410 | 0.030 |
Why?
|
| Premenopause | 1 | 2017 | 1039 | 0.030 |
Why?
|
| Rats, Inbred SHR | 2 | 2003 | 186 | 0.030 |
Why?
|
| Cholesterol, LDL | 2 | 2014 | 2403 | 0.030 |
Why?
|
| Fluorenes | 1 | 2014 | 160 | 0.030 |
Why?
|
| Lung Volume Measurements | 1 | 1994 | 381 | 0.030 |
Why?
|
| Clinical Trials as Topic | 1 | 2009 | 8054 | 0.030 |
Why?
|
| Fractures, Bone | 1 | 2005 | 2062 | 0.030 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 89 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 2 | 2021 | 7454 | 0.030 |
Why?
|
| Hepatitis B | 1 | 1998 | 711 | 0.030 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2014 | 304 | 0.030 |
Why?
|
| Health Facilities | 1 | 1997 | 578 | 0.030 |
Why?
|
| Titanium | 1 | 2015 | 495 | 0.030 |
Why?
|
| Immunity | 1 | 2018 | 1003 | 0.030 |
Why?
|
| Bronchoconstriction | 1 | 1993 | 141 | 0.020 |
Why?
|
| Melanoma | 1 | 2011 | 5706 | 0.020 |
Why?
|
| Environmental Policy | 1 | 2012 | 36 | 0.020 |
Why?
|
| Communication | 1 | 2006 | 3905 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 1994 | 963 | 0.020 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 453 | 0.020 |
Why?
|
| Tissue Scaffolds | 1 | 2018 | 951 | 0.020 |
Why?
|
| Activating Transcription Factor 4 | 1 | 2012 | 86 | 0.020 |
Why?
|
| Oils, Volatile | 1 | 1991 | 14 | 0.020 |
Why?
|
| United States Environmental Protection Agency | 1 | 1991 | 139 | 0.020 |
Why?
|
| Alkanes | 1 | 1991 | 39 | 0.020 |
Why?
|
| Caspase 1 | 1 | 2012 | 227 | 0.020 |
Why?
|
| Qualitative Research | 1 | 2022 | 3140 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2016 | 830 | 0.020 |
Why?
|
| Antigens, CD | 2 | 2018 | 4035 | 0.020 |
Why?
|
| Fasting | 1 | 2017 | 1610 | 0.020 |
Why?
|
| Interleukin-11 | 1 | 2010 | 59 | 0.020 |
Why?
|
| Dermatitis, Contact | 1 | 1991 | 134 | 0.020 |
Why?
|
| Autoantigens | 1 | 2015 | 890 | 0.020 |
Why?
|
| Dihydrouracil Dehydrogenase (NADP) | 1 | 2010 | 17 | 0.020 |
Why?
|
| Italy | 1 | 2013 | 856 | 0.020 |
Why?
|
| Lipocalins | 1 | 2011 | 161 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2013 | 486 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 1994 | 1587 | 0.020 |
Why?
|
| Dietary Fats | 1 | 1998 | 2003 | 0.020 |
Why?
|
| Genes | 1 | 1994 | 1824 | 0.020 |
Why?
|
| Nutritional Status | 1 | 2019 | 1628 | 0.020 |
Why?
|
| Smad3 Protein | 1 | 2010 | 166 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2012 | 251 | 0.020 |
Why?
|
| Acute-Phase Proteins | 1 | 2011 | 252 | 0.020 |
Why?
|
| Cell Count | 1 | 1994 | 1832 | 0.020 |
Why?
|
| Waist Circumference | 1 | 2014 | 935 | 0.020 |
Why?
|
| Michigan | 1 | 2011 | 330 | 0.020 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2010 | 108 | 0.020 |
Why?
|
| Bacterial Infections | 1 | 2018 | 1397 | 0.020 |
Why?
|
| Terminology as Topic | 1 | 1997 | 1542 | 0.020 |
Why?
|
| Multigene Family | 1 | 2013 | 1081 | 0.020 |
Why?
|
| Albumins | 2 | 2002 | 577 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2016 | 888 | 0.020 |
Why?
|
| Dogs | 1 | 2014 | 3845 | 0.020 |
Why?
|
| Hematuria | 1 | 1991 | 232 | 0.020 |
Why?
|
| Filtration | 1 | 2010 | 229 | 0.020 |
Why?
|
| Sulfates | 1 | 2010 | 379 | 0.020 |
Why?
|
| Morbidity | 1 | 1995 | 1755 | 0.020 |
Why?
|
| Methyl Parathion | 2 | 1999 | 7 | 0.020 |
Why?
|
| Mice, Knockout | 2 | 2018 | 14488 | 0.020 |
Why?
|
| Drug Prescriptions | 1 | 1999 | 1668 | 0.020 |
Why?
|
| Matched-Pair Analysis | 1 | 2010 | 285 | 0.020 |
Why?
|
| Databases, Factual | 2 | 2013 | 8080 | 0.020 |
Why?
|
| Infection Control | 1 | 2016 | 985 | 0.020 |
Why?
|
| Cell Line | 2 | 2015 | 15597 | 0.020 |
Why?
|
| Insurance Claim Reporting | 1 | 2010 | 166 | 0.020 |
Why?
|
| Carboplatin | 1 | 2012 | 797 | 0.020 |
Why?
|
| Magnetic Resonance Imaging, Cine | 1 | 2016 | 1091 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2012 | 753 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2017 | 1966 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2005 | 10474 | 0.020 |
Why?
|
| Fatty Acids | 1 | 2017 | 1812 | 0.020 |
Why?
|
| Menopause | 1 | 2017 | 1656 | 0.020 |
Why?
|
| T-Lymphocytes | 2 | 1996 | 10266 | 0.020 |
Why?
|
| Soy Foods | 1 | 2009 | 44 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2020 | 3044 | 0.020 |
Why?
|
| Horse Diseases | 1 | 2009 | 55 | 0.020 |
Why?
|
| Exercise | 2 | 2005 | 5955 | 0.020 |
Why?
|
| Visual Acuity | 1 | 1998 | 2714 | 0.020 |
Why?
|
| Antigen-Presenting Cells | 1 | 2012 | 960 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 2540 | 0.020 |
Why?
|
| Species Specificity | 2 | 2003 | 2415 | 0.020 |
Why?
|
| Swine | 1 | 2018 | 5995 | 0.020 |
Why?
|
| Aconitate Hydratase | 1 | 2008 | 17 | 0.020 |
Why?
|
| Horses | 1 | 2009 | 295 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2014 | 937 | 0.020 |
Why?
|
| Parents | 1 | 2002 | 3595 | 0.020 |
Why?
|
| Pedigree | 2 | 2012 | 4539 | 0.020 |
Why?
|
| Chromogenic Compounds | 1 | 2007 | 30 | 0.020 |
Why?
|
| Siblings | 1 | 2012 | 828 | 0.020 |
Why?
|
| Hepatitis C | 1 | 1998 | 1595 | 0.020 |
Why?
|
| Testosterone | 1 | 1998 | 2491 | 0.020 |
Why?
|
| Oxygen | 1 | 1999 | 4270 | 0.020 |
Why?
|
| Sus scrofa | 1 | 2009 | 430 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 275 | 0.020 |
Why?
|
| Treatment Failure | 1 | 2013 | 2661 | 0.020 |
Why?
|
| Genes, BRCA2 | 1 | 2010 | 593 | 0.020 |
Why?
|
| Myeloid Cells | 1 | 2012 | 839 | 0.020 |
Why?
|
| Outpatients | 1 | 1995 | 1600 | 0.020 |
Why?
|
| Adaptive Immunity | 1 | 2012 | 733 | 0.020 |
Why?
|
| Propaganda | 1 | 2006 | 7 | 0.020 |
Why?
|
| Chickens | 1 | 2009 | 845 | 0.020 |
Why?
|
| Databases, Protein | 1 | 2009 | 390 | 0.020 |
Why?
|
| Accident Prevention | 1 | 1987 | 76 | 0.020 |
Why?
|
| Genes, BRCA1 | 1 | 2010 | 755 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2009 | 1703 | 0.020 |
Why?
|
| Societies, Medical | 1 | 2019 | 3968 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 2008 | 236 | 0.020 |
Why?
|
| Wind | 1 | 2006 | 44 | 0.020 |
Why?
|
| Zimbabwe | 1 | 2006 | 135 | 0.020 |
Why?
|
| Legislation, Medical | 2 | 1976 | 99 | 0.020 |
Why?
|
| Colorectal Neoplasms, Hereditary Nonpolyposis | 1 | 2010 | 388 | 0.020 |
Why?
|
| Lipids | 1 | 2017 | 3343 | 0.020 |
Why?
|
| Ovalbumin | 2 | 1999 | 677 | 0.020 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1518 | 0.020 |
Why?
|
| Emergency Medical Services | 1 | 1997 | 1947 | 0.020 |
Why?
|
| Convalescence | 1 | 2006 | 107 | 0.020 |
Why?
|
| Meat | 1 | 2009 | 588 | 0.020 |
Why?
|
| Insulin-Secreting Cells | 1 | 2013 | 899 | 0.020 |
Why?
|
| Angiopoietin-1 | 1 | 2006 | 133 | 0.020 |
Why?
|
| Cystic Fibrosis | 1 | 2015 | 1294 | 0.020 |
Why?
|
| Bone Marrow Cells | 1 | 2013 | 2414 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 3929 | 0.020 |
Why?
|
| Ecuador | 1 | 2005 | 62 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2003 | 8128 | 0.020 |
Why?
|
| Refuse Disposal | 1 | 2005 | 31 | 0.020 |
Why?
|
| Clinical Trials, Phase II as Topic | 1 | 2008 | 640 | 0.020 |
Why?
|
| Women | 1 | 1987 | 225 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2015 | 22379 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2013 | 1388 | 0.010 |
Why?
|
| Finland | 1 | 2006 | 609 | 0.010 |
Why?
|
| Enzyme Induction | 2 | 2000 | 455 | 0.010 |
Why?
|
| Cell Movement | 1 | 2017 | 5210 | 0.010 |
Why?
|
| HL-60 Cells | 1 | 2005 | 364 | 0.010 |
Why?
|
| Postpartum Period | 1 | 2011 | 1198 | 0.010 |
Why?
|
| Quality Control | 1 | 2007 | 836 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 2012 | 2219 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 3 | 1999 | 6231 | 0.010 |
Why?
|
| Carcinoma, Papillary | 1 | 2009 | 793 | 0.010 |
Why?
|
| Propensity Score | 1 | 2012 | 1969 | 0.010 |
Why?
|
| rho-Associated Kinases | 1 | 2006 | 290 | 0.010 |
Why?
|
| Population Dynamics | 1 | 2006 | 314 | 0.010 |
Why?
|
| Pulmonary Gas Exchange | 1 | 2006 | 389 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1996 | 8542 | 0.010 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2007 | 596 | 0.010 |
Why?
|
| Echocardiography | 1 | 2016 | 5047 | 0.010 |
Why?
|
| Seafood | 1 | 2007 | 395 | 0.010 |
Why?
|
| Coronary Artery Disease | 1 | 2003 | 6568 | 0.010 |
Why?
|
| Comet Assay | 1 | 2003 | 74 | 0.010 |
Why?
|
| Clinical Trials, Phase III as Topic | 1 | 2008 | 879 | 0.010 |
Why?
|
| Ventricular Function, Left | 1 | 2016 | 3941 | 0.010 |
Why?
|
| Cattle | 1 | 2009 | 3819 | 0.010 |
Why?
|
| Instillation, Drug | 1 | 2002 | 32 | 0.010 |
Why?
|
| Hodgkin Disease | 1 | 1991 | 1384 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2008 | 686 | 0.010 |
Why?
|
| Affect | 1 | 2010 | 1495 | 0.010 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 4833 | 0.010 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2003 | 220 | 0.010 |
Why?
|
| Oils | 1 | 2002 | 54 | 0.010 |
Why?
|
| Immunoradiometric Assay | 1 | 2002 | 20 | 0.010 |
Why?
|
| Ventilation | 1 | 1983 | 129 | 0.010 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 1305 | 0.010 |
Why?
|
| Anti-HIV Agents | 1 | 2018 | 4573 | 0.010 |
Why?
|
| Toxicity Tests | 1 | 2002 | 114 | 0.010 |
Why?
|
| Decision Support Techniques | 1 | 2012 | 2008 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 6 | 1 | 2005 | 354 | 0.010 |
Why?
|
| Learning | 1 | 1992 | 1759 | 0.010 |
Why?
|
| Chromatography, Gas | 1 | 2002 | 150 | 0.010 |
Why?
|
| Glucose | 1 | 2014 | 4352 | 0.010 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 611 | 0.010 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2005 | 663 | 0.010 |
Why?
|
| Histocytochemistry | 2 | 1996 | 699 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2005 | 565 | 0.010 |
Why?
|
| Aminopropionitrile | 1 | 1981 | 9 | 0.010 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2001 | 84 | 0.010 |
Why?
|
| Conflict of Interest | 1 | 2006 | 556 | 0.010 |
Why?
|
| Chemokine CCL3 | 1 | 2000 | 85 | 0.010 |
Why?
|
| Chemokine CCL4 | 1 | 2000 | 127 | 0.010 |
Why?
|
| Chemokine CXCL2 | 1 | 2000 | 105 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2013 | 3109 | 0.010 |
Why?
|
| Ventilators, Mechanical | 1 | 1983 | 292 | 0.010 |
Why?
|
| Macrophage Inflammatory Proteins | 1 | 2000 | 122 | 0.010 |
Why?
|
| Gamma Rays | 1 | 2002 | 319 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2741 | 0.010 |
Why?
|
| Clinical Competence | 1 | 2016 | 4858 | 0.010 |
Why?
|
| Blood Vessels | 1 | 2006 | 1110 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 2000 | 775 | 0.010 |
Why?
|
| ADAM Proteins | 1 | 2002 | 242 | 0.010 |
Why?
|
| Attention | 1 | 2010 | 2424 | 0.010 |
Why?
|
| Immunity, Innate | 1 | 2012 | 3080 | 0.010 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2002 | 394 | 0.010 |
Why?
|
| Urination Disorders | 1 | 1981 | 236 | 0.010 |
Why?
|
| Space-Time Clustering | 1 | 1999 | 45 | 0.010 |
Why?
|
| Multiple Myeloma | 1 | 2017 | 5196 | 0.010 |
Why?
|
| Drug Tolerance | 2 | 1991 | 365 | 0.010 |
Why?
|
| Perinatal Care | 1 | 2002 | 245 | 0.010 |
Why?
|
| Endpoint Determination | 1 | 2002 | 592 | 0.010 |
Why?
|
| Nitrophenols | 1 | 1999 | 169 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 1550 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 18 | 1 | 1999 | 247 | 0.010 |
Why?
|
| Mental Disorders | 1 | 2019 | 6874 | 0.010 |
Why?
|
| Luminol | 1 | 1998 | 6 | 0.010 |
Why?
|
| Pesticide Residues | 1 | 1999 | 95 | 0.010 |
Why?
|
| Membrane Potentials | 1 | 2002 | 1090 | 0.010 |
Why?
|
| Flow Cytometry | 2 | 2001 | 5902 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2003 | 1081 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2007 | 2885 | 0.010 |
Why?
|
| Y Chromosome | 1 | 1999 | 205 | 0.010 |
Why?
|
| Family | 1 | 2009 | 3209 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2002 | 1156 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2001 | 710 | 0.010 |
Why?
|
| Energy Transfer | 1 | 1997 | 109 | 0.010 |
Why?
|
| Clinical Protocols | 1 | 2003 | 1443 | 0.010 |
Why?
|
| Organ Size | 1 | 2002 | 2267 | 0.010 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 1981 | 364 | 0.010 |
Why?
|
| Immunoglobulin Fab Fragments | 1 | 1999 | 446 | 0.010 |
Why?
|
| Luminescent Measurements | 1 | 1998 | 342 | 0.010 |
Why?
|
| Bronchoalveolar Lavage | 1 | 1996 | 131 | 0.010 |
Why?
|
| Hydrogen Sulfide | 1 | 1998 | 147 | 0.010 |
Why?
|
| Housekeeping, Hospital | 1 | 1996 | 17 | 0.010 |
Why?
|
| Diabetes Complications | 1 | 2003 | 1320 | 0.010 |
Why?
|
| Hospital Records | 1 | 1996 | 93 | 0.010 |
Why?
|
| Observer Variation | 1 | 2002 | 2622 | 0.010 |
Why?
|
| X Chromosome | 1 | 1999 | 819 | 0.010 |
Why?
|
| Fibrosis | 1 | 2003 | 2080 | 0.010 |
Why?
|
| Rats, Inbred Lew | 1 | 1997 | 1162 | 0.010 |
Why?
|
| Listeria monocytogenes | 1 | 1997 | 246 | 0.010 |
Why?
|
| Sterilization | 1 | 1996 | 132 | 0.010 |
Why?
|
| Hospital Departments | 1 | 1995 | 135 | 0.010 |
Why?
|
| Program Evaluation | 1 | 2003 | 2507 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2001 | 1505 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2000 | 3074 | 0.010 |
Why?
|
| Mutagenicity Tests | 1 | 1994 | 46 | 0.010 |
Why?
|
| Kuwait | 1 | 1994 | 94 | 0.010 |
Why?
|
| District of Columbia | 1 | 1994 | 159 | 0.010 |
Why?
|
| Stress, Physiological | 1 | 2000 | 1408 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1996 | 659 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 13421 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2008 | 3626 | 0.010 |
Why?
|
| Telephone | 1 | 1995 | 630 | 0.010 |
Why?
|
| Laboratories | 1 | 1995 | 463 | 0.010 |
Why?
|
| Nicaragua | 1 | 1991 | 29 | 0.010 |
Why?
|
| Erythrocyte Count | 1 | 1991 | 157 | 0.010 |
Why?
|
| Cell Survival | 1 | 2000 | 5777 | 0.010 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1996 | 716 | 0.010 |
Why?
|
| Cell Division | 1 | 1996 | 4473 | 0.010 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 1 | 1991 | 897 | 0.000 |
Why?
|
| Certification | 1 | 1992 | 420 | 0.000 |
Why?
|
| Railroads | 1 | 1985 | 63 | 0.000 |
Why?
|
| Aryl Hydrocarbon Hydroxylases | 1 | 1986 | 246 | 0.000 |
Why?
|
| Surgical Procedures, Operative | 1 | 1995 | 1932 | 0.000 |
Why?
|
| Hospitals | 1 | 1995 | 3886 | 0.000 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 1991 | 2568 | 0.000 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 1281 | 0.000 |
Why?
|
| Neurologic Examination | 1 | 1981 | 914 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1989 | 3840 | 0.000 |
Why?
|